Anda di halaman 1dari 39

DIABETES MELLITUS IN MALAYSIA

This bibliography is a collection of Malaysian research/publications on diabetes mellitus. The


search method follows the method that has been previously described.[1] In brief, clinical
research publications containing data on Malaysia for the period 2000-2014 were included
(last search date 28 Dec 2014). We have included conference proceedings (but not
conference abstracts), relevant theses/dissertation, books/book chapters, reports and clinical
practice guidelines. Where available, link to free full text is provided.
In view of the large number of items (n=679), this bibliography is divided into the seven
parts.
1. Diabetes mellitus, type 2 [Mesh term: Diabetes Mellitus, Type 2]
2. Diabetes mellitus, type 1 [Mesh term: Diabetes Mellitus, Type 1]
3. Gestational diabetes and diabetes in pregnancy [Mesh term: Diabetes, Gestational]
4. Diabetic nephropathy [Mesh term: Diabetic Nephropathies]
5. Diabetic neuropathy [Mesh term: Diabetic Neuropathies]
6. Diabetic retinopathy [Mesh term: Diabetic Retinopathy]
7. Diabetic foot [Mesh term: Diabetic Foot]
The preparation of this bibliography is funded by a grant from National Clinical Research
Centre to International Medical University (Project ID No. IMU R 150/2014). The project
leader is Professor CL Teng. Searchers were made by CL Teng, Zuhanariah Mohd Nordin, Goh
Cheng Chun and Ng Chun Sien. Kindly send enquiry about this bibliography to
tengcl@gmail.com
Reference:
1. Teng CL, Zuhanariah MN, Ng CS, et al. Bibliography of clinical research in Malaysia:
methods and brief results. Med J Malaysia 2014;69 Suppl A:4-7
http://www.e-mjm.org/2014/supplement-A/bibliography-of-clinical-research-inMalaysia.pdf.
PART 1: DIABETES MELLITUS, TYPE 2
Books, Book Chapters, Guidelines, Reports, Proceedings
1. Abdol Malek AA, Mohamed Mansor M, Salmah B, et al. Drug Utilization in the
Treatment of Diabetes Mellitus in the Ministry of Health Facilities. Kuala Lumpur:
Ministry of Health, Malaysia, 2013
http://www.pharmacy.gov.my/v2/sites/default/files/document-upload/drug-utilizationtreatment-diabetes-mellitus-moh-malaysia.pdf
2. Abida Haq, Syed M. Haq, Nurul Adha O, Tengku Malini, Tengku Mohamed Noor Izam,
Ratna Suny ME. Protocol Medication Therapy Adherence Clinic: Diabetes. Kuala
Lumpur: Ministry of Health, Malaysia, 2010
http://www.pharmacy.gov.my/v2/sites/default/files/document-upload/drug-utilizationtreatment-diabetes-mellitus-moh-malaysia.pdf
3. Annual Report of the Diabetes in Children & Adolescent Registry (DiCARE) 2006-2007.
Kuala Lumpur: Ministry of Health, 2008
4. Clinical Practice Guidelines: Management of Type 2 Diabetes Mellitus, Fourth Edition.
Kuala Lumpur: Ministry of Health, Malaysia, 2009.
http://www.acadmed.org.my/view_file.cfm?fileid=292
5. Diabetes Registry Malaysia: report of an audit of diabetes control and management
(January-December 2009). Kuala Lumpur: Clinical Research Centre, 2010

6. Feisul Idzwan M, Fatanah I, Nor Azlina AR. The burden of diabetes mellitus and its
related complications in government hospitals in Malaysia (1999-2004). Putrajaya:
Ministry of Health, Malaysia, 2007
7. Health technology assessment report: Management of diabetes melitus and
screening for microalbuminuria in diabetics. Kuala Lumpur: Ministry of Health,
Malaysia, 2004
http://www.moh.gov.my/attachments/713.pdf
8. Medical Nutrition Therapy Guideline for Type 2 Diabetes, Second Edition. Malaysian
Dietitians' Association, 2013
9. National Diabetes Registry Report, Volume 1 2009-2012. Ministry of Health, Malaysia,
2013
10. Noormah MD, Roza S. Health technology assessment report: Nutritional therapy as a
complement for diabetes and hypertension. Kuala Lumpur: Ministry of Health,
Malaysia, 2013
http://www.moh.gov.my/hta/Nutritional_Therapy_report.pdf
11. Practical Guide to Insulin Therapy in Type 2 Diabetes Mellitus. Ministry of Health,
Malaysia, 2011
12. User Manual: Diabetes clinical audit in health facilities. [Manual pengguna. Audit
klinikal diabetes di fasiliti kesihatan]. Kuala Lumpur: Ministry of Health, Malaysia,
2008
13. Wan Mohamad WB, Mastura I. Preliminary report of an audit of diabetes control and
management (DRM-ADCM) July to December 2008. Kuala Lumpur: Diabetes Registry
Malaysia, 2009
14. Wan Mohamad WB. Diabetes in Malaysia: Complications and Treatment. [Diabetes di
Malaysia: Komplikasi dan Rawatan]. Pulau Pinang: Penerbit Universiti Sains Malaysia,
2005
Dissertations, Theses
1. Abdul Majeed SAR. Evaluation of coronary heart disease risk among patients with
type 2 diabetes in Hospital Pulau Pinang, Malaysia. MSc Dissertation, Universiti Sains
Malaysia, 2011.
2. Abdul Rahman H. Body mass index and its associated morbidity among elderly
patients attending Klinik Kesihatan Parit Jawa, Muar. Dissertation, Universiti
Kebangsaan Malaysia, 2000.
3. Abougalambou SSI. Assessment of the clinical treatment outcomes and direct
medical costs among type 2 diabetes mellitus outpatients at the Hospital Universiti
Sains Malaysia. PhD Thesis, Universiti Sains Malaysia, 2011.
4. Ahmad Ihsan AB. Prevalence of testosterone deficiency syndrome among men with
type 2 diabetes in primary care clinic, University Malaya Medical Centre. M Fam Med
Dissertation, University of Malaya, 2012.
5. Ahmad Iskandar Zulkarnain J. Oculo-visual status of diabetics experiencing prolonged
hyperglycaemia. [Status okular dan visual pesakit diabetes tanpa retinopati yang
mengalami hiperglisemia berpanjangan]. Master Dissertation, Universiti Kebangsaan
Malaysia, 2000.
http://ptsldigital.ukm.my:8080/vital/access/services/Download/ukmvital:119/ABSTRAC
T
6. Ajay M. Vascular effects of flavonoids in hypertension and diabetes mellitus. PhD
Thesis, University of Malaya, 2006.
7. Akmal Naziah A. Factors influencing glycaemic control in older people with type 2
diabetes mellitus on oral hypoglycaemic therapy and attending a primary health care
centre in Negeri Sembilan, Malaysia. MSc Dissertation, Universiti Putra Malaysia,
2011. http://psasir.upm.edu.my/19677/1/IG_2011_1.pdf

8. Al-anbari HSN. Evaluation of metformin usage in treatment of patients with type-2


diabetes mellitus in Penang General Hospital. MSc (Pharmacy) Dissertation, Universiti
Sains Malaysia, 2008.
http://eprints.usm.my/10179/1/EVALUATION_OF_METFORMIN_USAGE_IN.pdf
9. Al-Hamodi ZH. Genetic polymorphisms of plasminogen activator inhibitor-1 and tissue
plasminogen activator in Malaysian subjects with type 2 diabetes. PhD Thesis,
University of Malaya, 2012.
10. Al-Maweri, Sadeq Ali Ali Mohammed. Prevalence of oral mucosal lesions and the
association between diabetes mellitus and oral precancerous lesions among Malay
patients attending Hospital Universiti Sains Malaysia. MSc Dissertation, Universiti
Sains Malaysia, 2009.
11. Alnajjar BOM. Computer-aided drug design of novel peroxisome proliferator-activated
receptor gamma activators for the treatment of type 2 diabetes mellitus. PhD Thesis,
Universiti Sains Malaysia, 2012.
12. al-Qazaz HKM. Assessment of knowledge and adherence to medication: a mixed
methodology study among patients with type-2 diabetes mellitus in Penang. PhD
Thesis, Universiti Sains Malaysia, 2011.
13. Al-Zurfi BMN. Selected anthropometric parameters in relation to glycaemic control
and associated factors in Malay diabetic type 2 patients in HUSM. MSc Dissertation,
Universiti Sains Malaysia, 2010.
14. Amrizal MN. A cost analysis of diabetes mellitus, pre-eclampsia and neonatal jaundice
in Hospital Universiti Sains Malaysia, Kubang Kerian. [Kajian kos rawatan pesakit bagi
ketiga-tiga penyakit diabetes mellitus, pre-eklampsia dan neonatal jaundis di Hospital
Universiti Sains Malaysia, Kubang Kerian.]. MPH Dissertation, Universiti Sains
Malaysia, 2009.
15. Chan HH. Salivary protein profiling for type 2 diabetes mellitus patients with and
without periodontitis. M Dent Sc Dissertation, University of Malaya, 2013.
16. Choo AJ. Data analysis for diabetic patients. MSc Dissertation, Universiti Sains
Malaysia, 2004.
17. Dharmendra H. The serological prevalence of Burkholderia pseudomallei infection
among asymptomatic patients with diabetes mellitus who are attending the
outpatient medical specialist clinic in University Malaya Medical Centre. Dissertation,
University of Malaya, 2001.
18. Eid Mohammad AM. Factors affecting diabetes control and dyslipidaemia among type
2 diabetes mellitus patients in Hospital Universiti Sains Malaysia. MSc Dissertation,
Universiti Sains Malaysia,
2003.http://eprints.usm.my/5569/1/Kaewalan_Diabetes_Dan_Dyslipidaemia.pdf
19. Elhadi IE. Identification of factors affecting blood pressure control in patients
admitted with hypertension in Penang General Hospital. Master of Science
(Pharmacy), Universiti Sains Malaysia, 2007.
http://eprints.usm.my/9650/1/IDENTIFICATION_OF_FACTORS_AFFECTING_BLOOD_PRES
SURE_CONTROL_IN_PATIENTS_ADMITTED_WITH_HYPERTENSION_IN_PENANG_GENERA
L_HOSPITAL.pdf.
20. Habshoh H. Prevalence of depression and associated factors in type 2 diabetes
mellitus patients attending outpatient clinic Pendang Health Centre, Kedah
Darulaman. M Fam Med Dissertation, Universiti Kebangsaan Malaysia, 2000.
21. Haryati H. A study on glycemic control among insulin-treated type 2 diabetes patients
attending diabetes centre, HUSM, Kelantan. MSc Dissertation, Universiti Sains
Malaysia, 2009.
22. Hasni I. Use of HbA1c in the diagnosis of type 2 diabetes mellitus in high risk group
attending Klinik Rawatan Keluarga Hospital Universiti Sains Malaysia.MSc
Dissertation, Universiti Sains Malaysia,

2006.http://eprints.usm.my/8288/1/STUDIES_ON_DIABETIC_AND_PREDIABETIC_VASCU
LAR_DISEASE_AND_THE_EFFECT_OF_SELECTED_THERAPEUTIC_MODALITIES_ON_ASSO
CIATED_VASCULOPATHY.pdf;.
23. Hasniza H. Prevalence of falls and its associates factors among elderly diabetes
attending Klinik Pakar Perubatan and Klinik Rawatan Keluarga Hospital Universiti
Sains Malaysia. MSc Dissertation, Universiti Sains Malaysia, 2009.
24. Hazizi AS. Cardiovascular disease risk factors among type 2 diabetes and normal
individuals. PhD Thesis, Universiti Putra Malaysia, 2010.
http://psasir.upm.edu.my/6611/1/FPSK%28P%29_2006_2A.pdf
25. Hazlin M. Medication nonadherence among patients with type 2 diabetes mellitus
attending a primary care clinic. MFamMed Dissertation, University of Malaya, 2012.
26. Ho BK. The association of central obesity with hypercholesterolemia. MFamMed
Dissertation, University of Malaya, 2000.
27. Ikhwan Sani M. Post operative morbidity and 3 years survival rate in diabetic and non
diabetic patients undergoing coronary artery bypass grafting in Hospital Universiti
Sains Malaysia. MSc Dissertation, Universiti Sains Malaysia, 2009.
28. Ishaq Aweis DM. Clinical outcomes and economic burden of patients having diabetes
mellitus and tuberculosis in three hospitals in Malaysia. PhD Thesis, Universiti Sains
Malaysia, 2011.
29. Izzul Syazwan S. Initiation Of Insulin In Type 2 Diabetes Mellitus Patient. Bachelor of
Pharmacy Dissertation, Universiti Teknologi MARA,
2010.http://eprints.uitm.edu.my/2219/1/IZZUL_SYAZWAN_SHUIB_10_24.pdf.
30. Johan RI. Serum neurophil gelatinase-associated lipocalin (NGAL) characteristics in
diabetic patients with renal impairment undergoing elective coronary angiogram in
University Malaya Medical Centre. M Int Med Dissertation, University of Malaya, 2012.
31. Kamarul Imran M. The validation of the Malay translated audit of diabetes-dependent
quality of life (ADDQOL). MSc Dissertation, Universiti Sains Malaysia, 2005.
32. Kareem Hamoodi H. Evaluation of type-2, diabetes mellitus among hepatitis B and C
patients in Penang General Hospital, Malaysia. MSc Dissertation, Universiti Sains
Malaysia, 2011.
33. Koo HC. A multiethnic study to determine the association of dietary intake and
physical activity with plasma adiponectin concentrations among type 2 diabetis
mellitus patients in Penang. MSc Dissertation, Universiti Sains Malaysia, 2012.
34. Kow FF. Dietary adherence and health belief among Malay with type 2 diabetes
mellitus patients in the Diabetes Centre, Hospital Universiti Sains Malaysia (HUSM).
Dissertation, Universiti Sains Malaysia, 2009.
35. Lau WK. Development of cell-free assay system for the screening of PPAR-gamma
ligands from natural products: in search for positive therapeutic agents for type 2
diabetes. PhD Thesis, Universiti Sains Malaysia, 2013.
36. Lee CS. The association of Fatty Acid Binding Protein polymorphism with obesity and
type 2 diabetes mellitus in Malaysian subjects. MMedSc Dissertation, University of
Malaya, 2010.
37. Loh BI. The association of glycemic index and dietary fiber with plasma adiponectin
and leptin concentrations among multiethnic patients with type 2 diabetes mellitus in
Penang general hospital. MSc Dissertation, Universiti Sains Malaysia, 2013.
38. Luqman I. Urine bisphenol A level in patients with diabetes mellitus and metabolic
syndrome. M Int Med Dissertation, University of Malaya, 2012.
39. Mahmoud Sadi MA. Economic, social and clinical evaluations of diabetes self
management program at Universiti Sains Malaysia Health Center: comparison
between structured and less structured educational programs. PhD Thesis, Universiti
Sains Malaysia, 2008. http://eprints.usm.my/8954/1/ECONOMIC

%2C_SOCIAL_AND_CLINICAL_EVALUATIONS_OF_DIABETES_SELF_MANAGEMENT_PROG
RAM_AT_UNIVERSITI_SAINS_MALAYSIA_HEALTH_CENTER.pdf.
40. Malik A. Influence of platelet rich plasma on osseointegration in controlled diabetic
patients. MSc Dissertation, Universiti Sains Malaysia, 2008.
41. Mardhiah A, Chua, SS and Chan, SP. Common problems associated with the use of
hypoglycaemic agents by diabetic patients. Dissertation, 2005.
42. Marilyn U. A cross sectional study on quality of life among non-insulin dependent
diabetes mellitus patients in Sarikei, Sarawak. Master Dissertation, Universiti
Kebangsaan Malaysia, 2007.
43. Mohamad Azfar Z. A comparison of quality of life based on Malay version audit of
diabetes-dependent quality of life (Malay ADDQL) scores between type 2 diabetes
mellitus patients on oral hypoglycemic agent only treatment versus insulin only or
combined insulin and oral hypoglycemic agent treatment in HUSM Kelantan. MSc
Dissertation, Universiti Sains Malaysia, 2011.
44. Mohamed Awad AAM. Pharmacoepidemiologic and direct medical cost evaluations of
type 2 diabetes mellitus in Universiti Sains Malaysia. MSc Dissertation, Universiti
Sains Malaysia, 2005.
45. Mohamed AAAE. The impact of compliance of the prescribers to the Malaysian
consensus for type 2 diabetes mellitus management for hospitalized Penang
hospital's patients and their self management. MSc Dissertation, Universiti Sains
Malaysia, 2009.
46. Mohd Dziehan M. Beliefs about medicine and medication adherence among malay
patients with type 2 diabetes mellitus in primary health care. Master of Pharmacy
Practice, Universiti Teknologi MARA, 2010.http://eprints.uitm.edu.my/7434/1/MOHD
%20DZIEHAN%20MUSTAPA%2010_24.pdf
47. Moy FM. Nutritional status, knowledge, attitude and practice of type 2 diabetes
patients. [Status pemakanan dan tahap pengetahuan sikap dan amalan pesakit
diabetes jenis 2]. Master Dissertation, Universiti Kebangsaan Malaysia, 2000.
48. Muhammad Huzaimi H. Association of TCF7L2 variants with type 2 diabetes mellitus
susceptibility and treatment outcome in multi-ethnic Malaysian population. MMedSc
Dissertation, University of Malaya, 2012.
49. Nik Sherina Haidi H. Continuity of care: Assessment of provider continuity and its
impact on diabetes mellitus in family practice. MFamMed Dissertation, University of
Malaya, 2000.
50. Noor Hasliza H. A study on the effect of oral hypoglycaemic agents on arterial
stiffness among Malay patients with type 2 diabetes mellitus. MSc Dissertation,
Universiti Sains Malaysia, 2006.
51. Noor Hasnita IM. Intrarenal resistive index (RI) in type 2 diabetes mellitus: correlation
with creatinine clearance and association with urinary albumin excretion. MSc
Dissertation, Universiti Sains Malaysia, 2009.
52. Nor Azwany Y. A study of the knowledge, attitude and practice and the effect of
ramadan fasting on glycemic control and hydration status of type 2 diabetic patients
in Hospital Universiti Sains Malaysia, Kubang Kerian, Kelantan. MSc Dissertation,
Universiti Sains Malaysia, 2003.
53. Nor Masniwati S. Evaluation of visual function, mascular thickness and quality of life
pre and post focal laser photocoagulation in diabetic macular oedema. MMed
Dissertation, Universiti Sains Malaysia, 2012.
54. Norazlin AK. A comparative study on economic burden between schizophrenia and
diabetes mellitus in Malaysian secondary hospital. MSc Dissertation, Universiti Sains
Malaysia, 2010.
55. Norhidayah MJ. Diabetes diagnosis and monitoring web based using Decision Support
System (DSS) approach. BSc Dissertation, Universiti Teknologi MARA, 2005.

http://eprints.uitm.edu.my/10435/1/NORHIDAYAH%20BINTI%20MOHD%20JUSOH
%2005_24.pdf.
56. Nur Aqilah AR. Quality of life of type 2 diabetes mellitus (T2DM) patients in the
endocrine clinic of Hospital Putrajaya. Bachelor of Pharmacy Dissertation, Universiti
Teknologi MARA,
2010.http://eprints.uitm.edu.my/2248/1/NUR_AQILAH_ABDUL_RAHMAN_10_24.pdf.
57. Nurkhairizan K. Pendekatan penaakulan berasaskan perancangan menu pemakanan
pesakit diabetes. Master Dissertation, Universiti Kebangsaan Malaysia, 2008.
58. Nursazwina AS. Development of web based fuzzy expert system for disease
diagnosis: diabetes diagnosis system. BSc Dissertation, Universiti Teknologi MARA,
2006.http://eprints.uitm.edu.my/2219/1/IZZUL_SYAZWAN_SHUIB_10_24.pdf;;.
59. Nurul Akmar G. Risk of coronary heart disease in type 2 diabetes mellitus patients in
Kelantan. MSc Dissertation, Universiti Sains Malaysia, 2011.
60. Nurul Azreen H. Depression and quality of life in patients with type 2 diabetes
mellitus. MPM Dissertation, University of Malaya, 2011.
61. Ooi CP. Application of a social cognitive theory model to analyse hypoglycaemic risk
factors in older patients with type 2 diabetes in two rural primary healthcare clinics in
Selangor, Malaysia. PhD Thesis, Universiti Putra Malaysia, 2010.
http://psasir.upm.edu.my/27002/1/IG%202011%204R.pdf.
62. Phang LL, Chua, SS and Chan, SP. Factors associated with medication adherence of
type 2 diabetic patients and the role of healthcare providers. Dissertation, University
of Malaya, 2006.
63. Rafidah G. Sistem pengkomputeran pengurusan diet bagi diabetes mellitus:
pengenalpastian keperluan maklumat, pembangunan sistem dan evaluasi formatif.
Master Dissertation, Universiti Kebangsaan Malaysia, 2005.
64. Raja Elina Afzan, Raja Ahmad. Determinants of exercise capacity in patients with
uncomplicated type 2 diabetes mellitus. MMedSc Dissertation, University of Malaya,
2005.
65. Renukanth PCR. Effect of periodontal intervention on periodontal disease and type 2
diabetes mellitus. M Clin Dent (Periodontology) Dissertation, University of Malaya,
2011.
66. Rosediani M. Assessing glycaemic control: a randomized control trial between fasting
and 2 hours postprandial blood glucose monitoring in type 2 diabetic patients
attending Klinik Rawatan Keluarga, Universiti Sains Malaysia, Kelantan. MSc
Dissertation, Universiti Sains Malaysia, 2005.
67. Rosmiza A. Prevalence of chronic kidney disease and its associated factors in type 2
diabetes mellitus. MFamMed Dissertation, University of Malaya, 2011.
68. Rozanah AR. Prevalence and associated risk factors of clostridium difficile infection in
type 2 diabetes mellitus patients treated with antibiotics. MSc Dissertation, Universiti
Sains Malaysia, 2010.
69. Salem SDH. Association of genetic polymorphism of hhex, igf2bp2 and slc30a8 with
glutamic acid decarboxylase antibody-negative diabetes and latent autoimmune
diabetes in adults (LADA) in Malaysians. MMedSc Dissertation, University of Malaya,
2013.
70. Salmiah MA. Type 2 diabetes in Malaysia: perspectives of Malay patients and their
health care professionals. PhD Thesis, University of Nottingham, 2006.
71. Samitah Z. Studies to determine the prevalence of candidate gene polymorphism and
their association with arterial stiffness in diabetes mellitus among Malays. MSc
Dissertation, Universiti Sains Malaysia, 2007.
72. Sayeeda R. Studies on diabetic and prediabetic vascular disease and the effect of
selected therapeutic modalities on associated vasculopathy. PhD Thesis, Universiti
Sains Malaysia,

2006.http://eprints.usm.my/8288/1/STUDIES_ON_DIABETIC_AND_PREDIABETIC_VASCU
LAR_DISEASE_AND_THE_EFFECT_OF_SELECTED_THERAPEUTIC_MODALITIES_ON_ASSO
CIATED_VASCULOPATHY.pdf.
73. Sharifah Izwan TO. Polymorphism of beta3-adrenergic receptor, leptin receptor,
glucocorticoid receptor and tumour necrosis factor-alpha gene among patients with
type 2 diabetes mellitus. [Polimorfisma gen reseptor 3-adrenergik, gen reseptor
leptin, gen reseptor glukokortikoid dan gen faktor nekrosis tumor- pada pesakit
diabetes melitus jenis 2]. PhD Thesis, Universiti Sains Malaysia,
2010.http://eprints.usm.my/9776/1/POLIMORFISMA_GEN_RESEPTOR_%CE%B23ADRENERGIK%2C_GEN_RESEPTOR_LEPTIN
%2C_GEN_RESEPTOR_GLUKOKORTIKOID_DAN_GEN_FAKTOR.pdf.
74. Shori AB. Inhibitory potential of Azadirchta indica-enriched yogurt against key
enzymes linked to type-2 diabetes and hypertension. MSc Dissertation, University of
Malaya, 2009.
75. Shubashini G. Pharmaceutical care for patients with tuberculosis and diabetes
mellitus in Malaysia : a complex intervention. PhD Thesis, University of Nottingham,
2012.
76. Sim SK. Oxidative dna damage in leukocytes and its association with metabolic
control in diabetic patients with and without microalbuminuria. MSc Dissertation,
Universiti Putra Malaysia,
2001.http://psasir.upm.edu.my/11220/1/FPSK_M_2001_8_A.pdf.
77. Siti Rafiaah I. Prevalence of glucose intolerance and factors that influence it among
pregnant women with and without risk at Antenatal Clinic, HUKM. Dissertation,
Universiti Kebangsaan Malaysia, 2000.
78. Sudzilla N. Antiproteinuric effect of Rasilez (aliskiren) in hypertensive/normotensive
type 2 diabetes added on to ACEI base treatment. MMed Dissertation, Universiti Sains
Malaysia, 2013.
79. Suhaimi MI. Erectile dysfunction among diabetic patients attending Diabetic Clinic,
Klinik Kesihatan Bandar, Kota Bharu and Hospital Universiti Sains Malaysia, Kubang
Kerian, Kelantan. Dissertation, Universiti Sains Malaysia, 2002.
80. Suhaiza S. The impact of structured healthy lifestyle programs among type 2 diabetic
patients in Pasir Puteh, Kelantan: a controlled trial .MSc Dissertation, Universiti Sains
Malaysia, 2001.
81. Sukhbir KJS. A study of glycaemic control and the associated factors among diabetic
patients at the Sungai Dua Health Clinic Penang. Dissertation, Universiti Kebangsaan
Malaysia, 2000.
82. Sulaila B. A study on the effects of Andrographis paniculata (hempedu bumi) on
serum protein C, protein S activity and fasting blood glucose in patients with type 2
diabetes mellitus. MMed Dissertation, Universiti Sains Malaysia, 2011.
83. Suraya M. Factors associated with unawarness of correct FBG target among type 2
diabetes mellitus patients in Hospital Universiti Sains Malaysia. MMed Dissertation,
Universiti Sains Malaysia, 2012.
84. Tan MY. Self-care practices of adults with poorly controlled diabetes mellitus in
Malaysia. Doctorate in Nursing Thesis, University of Adelaide, 2009.
http://digital.library.adelaide.edu.au/dspace/bitstream/2440/57031/1/02whole.pdf.
85. Tan SF. Decline rate of kidney function in patients with type 2 diabetes mellitus and
the associated factors - a 10-year retrospective cohort study. MFamMed Dissertation,
University of Malaya, 2012.
86. Tengku Ahmad Damitri Al-Astani TD. Expression of apoptosis markers in the skin
microvasculature of patients with diabetes mellitus type 2 at Hospital Universiti Sains
Malaysia. MSc Dissertation (Pathology), Universiti Sains Malaysia,
2008.http://eprints.usm.my/9891/1/EXPRESSION_OF_APOPTOSIS_MARKERS_IN_THE_S

KIN_MICROVASCULATURE_OF_PATIENTS_WITH_DIABETES_MELLITUS_TYPE_2_AT_HOSPI
TAL_UNIVERSITI_SAINS_MALAYSIA.pdf.
87. Tengku Norbanee TH. A study of microalbuminuria and associated factors in patients
with type 2 diabetes mellitus in Hospital Universiti Sains Malaysia, Kelantan. MSc
Dissertation, Universiti Sains Malaysia, 2003.
88. Vasudevan R. Analysis of Genetic Polymorphisms as Risk Factors in Essential
Hypertension and Type 2 Diabetes Mellitus among Malaysians. PhD Thesis, Universiti
Putra Malaysia, 2009. http://psasir.upm.edu.my/7122/.
89. Vithyatheri G. A system for diagnosing diabetic patients using rule-based reasoning.
M Comp Sc Dissertation, University of Malaya, 2011.
90. Wan Syamimee WG. Combination therapy for optimum glycaemic control: a
randomized open label trial comparing rosiglitazone with combination sulphonylureas
and metformin tablets in type 2 diabetes mellitus. MSc Dissertation, Universiti Sains
Malaysia, 2006.
91. Yusliza Azreen MY. A study on the effect of cabergoline in patients with type 2
diabetes mellitus and metabolic syndrome. MMed Dissertation, Universiti Sains
Malaysia, 2013.
92. Zaki Ghaith NF. Evaluation of combined metformin-lovastatin therapy in the
treatment of diabetic type 2 patients with dyslipidemia in Hospital Pulau Pinang. MSc
Dissertation, Universiti Sains Malaysia, 2010.
93. Zukri MA. The quality of care and complications status among patients with 15 years
history of diabetes mellitus in HUSM. MSc Dissertation, Universiti Sains Malaysia,
2005.
Reviews, Editorials, Commentaries
1. Abdulameer SA, Syed Azhar SS, Mohd Azmi AH, et al. Osteoporosis and type 2
diabetes mellitus: what do we know, and what we can do? Patient Prefer Adherence
2012;6:435-48
http://www.dovepress.com/osteoporosis-and-type-2-diabetes-mellitus-what-do-weknow-and-what-we--peer-reviewed-article-PPA
2. Amudha K, Sivalal S, Ng SH. Social support in type II diabetes care: a case of too
little, too late. Diabetes Metab Syndr Obes 2012;5:407-17
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514066
3. Anuar Zaini MZ. Where is Malaysia in the midst of the Asian epidemic of diabetes
mellitus? Diabetes Res Clin Pract 2000;50 Suppl 2:S23-8
4. Balakumar P, Sundram K, Dhanaraj SA. Dapagliflozin: Glucuretic action and beyond.
Pharmacol Res 2014;82:34-9
5. Chan JCN, Chan SP, Deerochanawong C, et al. Diabetic dyslipidaemia in Asian
populations in the Western Pacific Region: what we know and don't know. Diabetes
Res Clin Pract 2011;94(1):1-13
6. Erejuwa OO, Siti Amrah S, Mohd Suhaimi AW. Honey--a novel antidiabetic agent. Int J
Biol Sci 2012;8(6):913-34
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399220/pdf/ijbsv08p0913.pdf
7. Erejuwa OO, Siti Amrah S, Mohd Suhaimi AW. Oligosaccharides might contribute to
the antidiabetic effect of honey: a review of the literature. Molecules 2011;17(1):24866
8. Haghverdizadeh P, Haerian M, Haghverdizadeh P, et al. ABCC8 genetic variants and
risk of diabetes mellitus. Gene 2014;545(2):198-204
9. Hanis HH, Morris MJ, Kavurma MM. On the TRAIL of obesity and diabetes. Trends
Endocrinol Metab 2013;24(11):578-87

10. Jeyamalar R, Lopez EA, Rahajoe AU, et al. Women's cardiovascular health:
perspectives from South-East Asia. Nat Rev Cardiol 2012;9(8):464-77
11. Kavitha N, De S, Kanagasabai S. Oral hypoglycemic agents in pregnancy: An update. J
Obstet Gynaecol India 2013;63(2):82-7
12. Khaled AA, Sekaran M, Ikram Shah I. N(epsilon)-(carboxymethyl)lysine and coronary
atherosclerosis-associated low density lipoprotein abnormalities in type 2 diabetes:
current status. J Clin Biochem Nutr 2009;44(1):14-27
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613495
13. Laitiff AA, Teoh SL, Das S. Wound healing in diabetes mellitus: traditional treatment
modalities. Clin Ter. 2010;161(4):359-64
14. Liew AKC, Punnanithinont N, Lee YC, et al. Effect of non-surgical periodontal
treatment on HbA1c: a meta-analysis of randomized controlled trials. Aust Dent J
2013;58(3):350-7
15. Lock JH, Fong KC. Retinal laser photocoagulation. Med J Malaysia 2010;65(1):88,94;
quiz 95
http://www.e-mjm.org/2010/v65n1/Retinal_Laser_Photocoagulation.pdf
16. Lye HS, Kuan CY, Ewe JA, et al. The improvement of hypertension by probiotics:
effects on cholesterol, diabetes, renin, and phytoestrogens. Int J Mol Sci
2009;10(9):3755-75
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769158
17. Maimunah M, Mazza D. Preconception care of women with diabetes: a review of
current guideline recommendations. BMC Womens Health 2010;10:5,6874-10-5
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834595
18. Mafauzy M. Diabetes mellitus in Malaysia. Med J Malaysia 2006;61(4):397-8
http://www.e-mjm.org/2006/v61n4/Diabetes_Mellitus_Malaysia.pdf
19. Mustaffa E. Diabetes epidemic in Malaysia. Med J Malaysia 2004;59(3):295-6
http://www.e-mjm.org/2004/v59n3/Diabetes.pdf
20. Masakazu T, Kousuke O, Tatsuya T, et al. Ethnic difference in patients with type 2
diabetes mellitus in inter-East Asian populations: a systematic review and metaanalysis focusing on fasting serum insulin. Diabetes Res Clin Pract 2008;81(3):370-6
21. Matough FA, Siti B B, Zariyantey AH, et al. The role of oxidative stress and
antioxidants in diabetic complications. Sultan Qaboos Univ Med J 2012;12(1):5-18
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286717/pdf/squmj-12-5.pdf
22. Mu YM, Misra A, Adam JMF, et al. Managing diabetes in Asia: overcoming obstacles
and the role of DPP-IV inhibitors. Diabetes Res Clin Pract 2012;95(2):179-88
23. Muhaya M. The eye in diabetes. Hosp Med 2003;64(11):673-6
24. Naing C, Mak JW, Wai N, et al. Diabetes and infections-hepatitis C: is there type 2
diabetes excess in hepatitis C infection? Curr Diab Rep 2013;13(3):428-34
25. Ng CJ, Liew SM, Vethakkan SR, et al. Patientadjusted versus health professional
adjusted insulin dosing for type 2 diabetes mellitus. The Cochrane Library 2013;(6)
26. Nik Ritza Kosai, Nik Mahmood. Is bariatic surgery the cure for diabetes mellitus?
Medicine & health 2013;8(2):52-4
http://www.medicineandhealthukm.com/system/files/article/2014/Editorial.pdf
27. Ong HT, Cheah JS. Choice of antihypertensive drug in the diabetic patient.
MedGenMed 2005;7(2):74
http://www.medscape.org/viewarticle/502546
28. Ooi CP, Loke SC. Colesevelam for type 2 diabetes mellitus: an abridged Cochrane
review. Diabet Med 2014;31(1):2-14
http://onlinelibrary.wiley.com/doi/10.1111/dme.12295/pdf
29. Ooi CP, Loke SC. Sweet potato for type 2 diabetes mellitus. Cochrane Database Syst
Rev 2013;9:CD009128

30. Ooi CP, Loke SC. Colesevelam for type 2 diabetes mellitus. Cochrane Database Syst
Rev 2012;12:CD009361
31. Ooi CP, Zaitun Y, Tengku Aizan H. Momordica charantia for type 2 diabetes mellitus.
Cochrane Database Syst Rev 2012;8:CD007845
32. Ramadas A, Quek KF, Chan CK, et al. Web-based interventions for the management
of type 2 diabetes mellitus: a systematic review of recent evidence. Int J Med Inform
2011;80(6):389-405
http://www.ijmijournal.com/article/S1386-5056%2811%2900047-5/pdf
33. Sayeeda R, Tahminur R, Aziz Al-Shafi I, et al. Diabetes-associated macrovasculopathy:
pathophysiology and pathogenesis. Diabetes Obes Metab 2007;9(6):767-80
34. Sazlina SG, Browning C, Mohd Shajahan MY. Interventions to promote physical activity
in older people with type 2 diabetes mellitus: a systematic review. Front Public Health
2013;1:71
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870318/pdf/fpubh-01-00071.pdf
35. Shafie O, Fatanah I, Noor Azah D. Diabetes program in Malaysia - current and future.
NCD Malaysia 2004;3(2):6-12
36. Sheu WHH, Azhari R, Mithal A, et al. Addressing the burden of type 2 diabetes and
cardiovascular disease through the management of postprandial hyperglycaemia: an
Asian-Pacific perspective and expert recommendations. Diabetes Res Clin Pract
2011;92(3):312-21
37. Subramanian K, Sekaran M, Qvist R, et al. F(2)-isoprostanes as novel biomarkers for
type 2 diabetes: a review. J Clin Biochem Nutr 2009;45(1):1-8
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704321/pdf/jcbn-45-1.pdf
38. Thent ZC, Das S, Henry LJ. Role of exercise in the management of diabetes mellitus:
the global scenario. PLoS One 2013;8(11):e80436
http://www.plosone.org/article/fetchObject.action?uri=info%3Adoi
%2F10.1371%2Fjournal.pone.0080436&representation=PDF
39. Velayudhan M. Managing diabetes during the Muslim fasting month of Ramadan. Med
J Malaysia 2012;67(3):353,4; quiz 355
http://www.e-mjm.org/2012/v67n3/Diabetes.pdf
40. Wong RSY. Extrinsic factors involved in the differentiation of stem cells into insulinproducing cells: an overview. Exp Diabetes Res 2011;2011:406182
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124109
41. Wong TW. Design of oral insulin delivery systems. J Drug Target 2010;18(2):79-92
42. Wong TW. Chitosan and its use in design of insulin delivery system. Recent Pat Drug
Deliv Formul 2009;3(1):8-25
43. Yogarabindranath SN. Influence of diabetes mellitus and risk factors in activating
latent tuberculosis infection: a case for targeted screening in Malaysia. Med J
Malaysia 2012;67(5):467-72
http://www.e-mjm.org/2012/v67n5/latent-tuberculosis-infection.pdf
44. Zainal Ariff AR, Hamimah H, Bunyarit SS. Clinical patterns of oro-facial infections.
Annals of Dentistry University of Malaya 2005;12(1):18-23
http://ejum.fsktm.um.edu.my/ArticleInformation.aspx?ArticleID=372
45. Zanariah H, Hamdy O, Chia YC, et al. Transcultural Diabetes Nutrition Algorithm: A
Malaysian Application. Int J Endocrinol 2013;2013:679396
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872099
46. Zar CT, Das S. Potential effect of herbs on diabetic hypertension: alternative medicine
treatment modalities. Clin Ter 2013;164(6):529-35
Original research

VARIOUS SETTINGS, EXCEPT PRIMARY CARE


1. Abdul Hamid J, Azmi MT. Predictors of survival among end stage renal failure patients
undergoing dialysis treatment in Pahang from 2000 TO 2004. Jurnal Kesihatan
Masyarakat 2009;15(1):76-84
http://journalarticle.ukm.my/4626/1/Vol15(1)-azimatun.pdf
2. Abdulameer SA, Syed Azhar SS, Mohd Azmi AH, et al. Psychometric properties of the
Malay version of the Osteoporosis Health Belief Scale (OHBS-M) among type 2
diabetic patients. Int J Rheum Dis 2014;17(1):93-105
3. Abdulameer SA, Syed Azhar SS, Mohd Azmi AH, et al. Psychometric properties and
osteoprotective behaviors among type 2 diabetic patients: osteoporosis self-efficacy
scale Malay version (OSES-M). Osteoporos Int 2013;24(3):929-40
4. Abdulameer SA, Syed Azhar SS, Mohd Azmi AH, et al. Psychometric properties of
Osteoporosis Knowledge Tool and self-management behaviours among Malaysian
type 2 diabetic patients. J Community Health 2013;38(1):95-105
5. Abougalambou SSI, Abougalambou ASI. A study evaluating prevalence of
hypertension and risk factors affecting on blood pressure control among type 2
diabetes patients attending teaching hospital in Malaysia. Diabetes Metab Syndr
2013;7(2):83-6
6. Abougalambou SSI, Abougalambou ASI, Syed Azhar SS, et al. Prevalence of
hypertension, control of blood pressure and treatment in hypertensive with type 2
diabetes in Hospital University Sains Malaysia. Diabetes Metab Syndr 2011;5(3):115-9
7. Abougalambou SSI, Mohd Azmi AH, Syed Azhar SS, et al. Prevalence of vascular
complications among type 2 diabetes mellitus outpatients at teaching hospital in
Malaysia. Journal of Diabetes & Metabolism 2011;2(1):1000115
http://omicsonline.org/2155-6156/2155-6156-2-115.pdf
8. Abougalambou SSI, Mafauzy M, Syed Azhar SS, et al. Current clinical status and
complications among type 2 diabetic patients in Universiti Sains Malaysia hospital.
International Journal of Diabetes Mellitus 2010;2(3):184-8
9. Abougalambou SSI, Syed Azhar SS, Syed Wasif G, et al. Evaluation of direct medical
cost among outpatients of type 2 diabetes mellitus: cost analysis in teaching hospital
of Malaysia. Folia Medica Facultatis Medicinae Universitatis Saraeviensis (Journal of
Medical Faculty University of Sarajevo, Bosnia & Herzegovina) 2010;45(1):3-8
http://mf.unsa.ba/podaci/folia/Folia%20medica%2045-1.pdf
10. Adibah Hanim I, Rawa B, Hatta S, et al. Factor analysis study on sexual responses in
women with type 2 diabetes mellitus. Compr Psychiatry 2014;55 Suppl 1:S34-7
11. Adibah Hanim I, Rawa B, Hatta S, et al. Orgasmic dysfunction among Malay diabetic
women in Malaysia. Compr Psychiatry 2014;55 Suppl 1:S29-33
12. Agarwal R, Siti Amrah S, Mafauzy M. Open label clinical trial to study adverse effects
and tolerance to dry powder of the aerial part of andrographis paniculata in patients
type 2 with diabetes mellitus. Malays J Med Sci 2005;12(1):13-9
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349408
13. Albaroodi KAI, Syed Sulaiman SA, Awaisu A. Evaluation of the most commonly used
anti-diabetic drugs at a hospital in northern part of Peninsular Malaysia. International
Journal of Medical and Pharmaceutical Sciences 2013;3(6).
http://www.scopemed.org/fulltextpdf.php?mno=34156
14. Al-Hamodi Z, Saif-Ali R, Ikram Shah I, et al. Effect of plasminogen activator inhibitor-1
and tissue plasminogen activator polymorphisms on susceptibility to type 2 diabetes
in Malaysian subjects. J Biomed Biotechnol 2012;2012:234937
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3336151
15. Al-Hamodi Z, Ikram Shah I, Saif-Ali R, et al. Association of plasminogen activator
inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic

syndrome in Malaysian subjects. Cardiovasc Diabetol 2011;10:23,2840-10-23


http://www.cardiab.com/content/pdf/1475-2840-10-23.pdf.
16. Al-Hamodi ZH, Saif-Ali R, Ikram Shah I, et al. Plasminogen activator inhibitor-1 4G/5G
polymorphism is associated with metabolic syndrome parameters in Malaysian
subjects. J Clin Biochem Nutr 2012;50(3):184-9
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334369
17. Ali RM, Degenhardt R, Robaayah Z, et al. Paclitaxel-eluting balloon angioplasty and
cobalt-chromium stents versus conventional angioplasty and paclitaxel-eluting stents
in the treatment of native coronary artery stenoses in patients with diabetes mellitus.
EuroIntervention 2011;7 Suppl K:K83-92
18. Al-Maweri SAA, Noorliza Mastura I, Abdul Rashid I, et al. Prevalence of oral mucosal
lesions in patients with type 2 diabetes attending Hospital Universiti Sains Malaysia.
Malays J Med Sci 2013;20(4):39-46
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3773351
19. Al-Qazaz HK, Mohd Azmi AH, Asrul Akmal S, et al. Perception and knowledge of
patients with type 2 diabetes in Malaysia about their disease and medication: a
qualitative study. Res Social Adm Pharm 2011;7(2):180-91
20. Al-Qazaz HK, Sulaiman SA, Mohd Azmi AH, et al. Diabetes knowledge, medication
adherence and glycemic control among patients with type 2 diabetes. Int J Clin
Pharm 2011;33(6):1028-35
http://www.researchgate.net/publication/51798593_Diabetes_knowledge_medication_
adherence_and_glycemic_control_among_patients_with_type_2_diabetes/file/79e4150
4b611ebef28.pdf.
21. Al-Qazaz HK, Mohd Azmi AH, Asrul Akmal S, et al. The 14-item Michigan Diabetes
Knowledge Test: translation and validation study of the Malaysian version. Practical
Diabetes International 2010;27(6):238-41
http://www.thecochranelibrary.com/userfiles/espdi/file/238_241_PDI_JA.pdf.
22. Al-Qazaz HK, Mohd Azmi AH, Asrul AS, et al. The eight-item Morisky Medication
Adherence Scale MMAS: translation and validation of the Malaysian version. Diabetes
Res Clin Pract 2010;90(2):216-21
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109726
23. Amudha K, Choy AM, Mohamed R. M, et al. Short-term effect of atorvastatin on
endothelial function in healthy offspring of parents with type 2 diabetes mellitus.
Cardiovasc Ther 2008;26(4):253-61
24. Amudha K, Chee KH, Tan KS, et al. Prevalence of peripheral artery disease in urban
high-risk Malaysian patients. Int J Clin Pract 2003;57(5):369-72
25. Annemans L, Demarteau N, Hu S, et al. An Asian regional analysis of costeffectiveness of early irbesartan treatment versus conventional antihypertensive, late
amlodipine, and late irbesartan treatments in patients with type 2 diabetes,
hypertension, and nephropathy. Value Health 2008;11(3):354-64
26. Aravind SR, Shaiful Bahari I, Balamurugan R, et al. Hypoglycemia in patients with
type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea
during Ramadan: a randomized, pragmatic study. Curr Med Res Opin
2012;28(8):1289-96
27. Aravind SR, Al Tayeb K, Shaiful Bahari I, et al. Hypoglycaemia in sulphonylureatreated subjects with type 2 diabetes undergoing Ramadan fasting: a five-country
observational study. Curr Med Res Opin 2011;27(6):1237-42
28. Asma A, Azmi MN, Mazita A, et al. A single blinded randomized controlled study of the
effect of conventional oral hypoglycemic agents versus intensive short-term insulin
therapy on pure tone audiometry in type II diabetes mellitus. Indian J Otolaryngol
Head Neck Surg 2011;63(2):114-8

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102159/pdf/12070_2011_Article_132.p
df
29. Assila AH, Seak YS, Goh ZP, et al. What contributes to the progression of chronic
kidney disease in type 2 diabetic patients? International Journal of Public Health
Research 2011;1(1):40-7
http://journalarticle.ukm.my/3343/1/vol%25201%2520no%25201%25202011_6.pdf
30. Aswany N, Ismail AA, Wan Mohamad WB, et al. Effect of Ramadan fasting on glycemic
status of type 2 diabetic patients in Northern Malaysia. International Medical Journal
(IIUM) 2003;2(2).
31. Aye M, Malek S. Waist circumference and BMI cut-off points to predict risk factors for
metabolic syndrome among outpatients in a district hospital. Singapore Med J
2012;53(8):545-50
http://www.sma.org.sg/UploadedImg/files/SMJ/5308/5308a8.pdf
32. Azarisman Shah MS, Aszrin A, Marzuki AO, et al. Blood pressure control among
diabetic hypertensives under cardiology follow-up at a regional hospital in rural
Malaysia. Southeast Asian J Trop Med Public Health 2010;41(4):973-81
33. Azidah AK, Hasniza H, Zunaina E. Prevalence of falls and its associated factors among
elderly diabetes in a tertiary center, Malaysia. Curr Gerontol Geriatr Res
2012;2012:539073
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369479
34. Azidah AK, Hasniza H. Prevalence of falls in elderly men with diabetes in Diabetic
Clinic Universiti Sains Malaysia Hospital, Malaysia. Journal of Men's Health 2011;8
Suppl 1:S91-3
35. Azizi A, Rafidah Hanim M, Tariq AR. Effects of irbesartan on beta-cell function and
insulin sensitivity in hypertensive and hypertensive diabetic subjects. International
Medical Journal (IIUM) 2005;4(1).
36. Azura Dina M, Wong M, Norlela S, et al. Prevalence of sexual dysfunction among
premenopausal women with and without type 2 diabetes mellitus. Journal of
Endocrinology and Metabolism 2013;3(1):29-39
http://www.jmems.org/index.php/jmems/article/view/75/59
37. Badariah A, Khalid AK, Quek KF, et al. Knowledge of diabetes and lifestyle behaviour
amongst indigenous population in Peninsular Malaysia. Med J Malaysia
2013;68(4):309-14
http://www.e-mjm.org/2013/v68n4/knowledge-of-diabetes.pdf
38. Badariah A, Ramadas A, Quek KF. The development and validation of diabetes
knowledge questionnaire for the Indigenous population in Malaysia. Med J Malaysia
2010;65(4):273-6
http://www.e-mjm.org/2010/v65n4/Diabetes_Knowledge.pdf
39. Barakatun Nisak MY, Ruzita AT, Norimah AK, et al. Improvement of dietary quality
with the aid of a low glycemic index diet in Asian patients with type 2 diabetes
mellitus. J Am Coll Nutr 2010;29(3):161-70
40. Barakatun Nisak MY, Ruzita AT, Norimah AK, et al. Acute effect of low and high
glycemic index meals on post-prandial glycemia and insulin responses in patients
with type 2 diabetes mellitus. Malaysian Journal of Medicine and Health Sciences
2009;5(1):11-20
http://medic.upm.edu.my/images/stories/journal/VOL5NO1_JANUARY2009.pdf
41. Barnett AH, Krentz AJ, Strojek K, et al. The efficacy of self-monitoring of blood glucose
in the management of patients with type 2 diabetes treated with a gliclazide modified
release-based regimen. A multicentre, randomized, parallel-group, 6-month
evaluation (DINAMIC 1 study). Diabetes Obes Metab 2008;10(12):1239-47
https://www.cgsmedicare.com/jc/MDCorner/BGM/29.pdf

42. Bauman A, Phongsavan P, Schoeppe S, et al. Noncommunicable disease risk factors


and socioeconomic inequalities what are the links? A multicountry analysis of
noncommunicable disease surveillance data. Report to the WHO Regional Office for
the Western Pacific.
2010;http://www.wpro.who.int/publications/docs/WHOSESFINALforupload.pdf
43. Bawazir A, Gharebaghi R, Hussein A, et al. Non-arteritic anterior ischaemic optic
neuropathy in Malaysia: a 5 years review. Int J Ophthalmol 2011;4(3):272-4
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340813/pdf/ijo-04-03-272.pdf
44. Biswas R, Maniam J, Lee EWH, et al. User-driven health care: answering
multidimensional information needs in individual patients utilizing post-EBM
approaches: an operational model. J Eval Clin Pract 2008;14(5):750-60
45. Buranakitjaroen P, Mangklabruks A, Leungwattanakij S, et al. Efficacy and safety of
sildenafil in Asian males with erectile dysfunction and cardiovascular risk. J Med
Assoc Thai 2007;90(6):1100-8
46. Chan C, Robaayah Z, Upendra K, et al. A randomized comparison of sirolimuseluting
versus bare metal stents in the treatment of diabetic patients with native coronary
artery lesions: The DECODE study. Catheterization and Cardiovascular Interventions
2008;72(5):591-600
47. Chan JCN, Wat NMS, So WY, et al. Renin angiotensin aldosterone system blockade
and renal disease in patients with type 2 diabetes. An Asian perspective from the
RENAAL Study. Diabetes Care 2004;27(4):874-9
http://care.diabetesjournals.org/content/27/4/874.full.pdf
48. Chan SP, Ji LN, Nitiyanant W, et al. Hypoglycemic symptoms in patients with type 2
diabetes in Asia-Pacific-Real-life effectiveness and care patterns of diabetes
management: the RECAP-DM study. Diabetes Res Clin Pract 2010;89(2):e30-2
49. Chan HH, Zubaidah HAR, Jessie K, et al. Salivary proteins associated with
periodontitis in patients with type 2 diabetes mellitus. Int J Mol Sci 2012;13(4):464254
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3344237/pdf/ijms-13-04642.pdf
50. Chan WK, Tan ATB, Vethakkan SR, et al. Non-alcoholic fatty liver disease in diabetics-prevalence and predictive factors in a multiracial hospital clinic population in
Malaysia. J Gastroenterol Hepatol 2013;28(8):1375-83
51. Chee EK, Kwan MK, Khoo EH. Necrotizing fasciitis of the lower limb - a prospective
study of prognostic factors affecting mortality. Malays Orthop J 2009;3(1):32-5
http://www.morthoj.org/2009v3n1/Necrotizing_Fasciitis_lower_limb.pdf.
52. Chia YC, Srinivas P. Cardiovascular disease risk in a semirural community in Malaysia.
Asia Pac J Public Health 2009;21(4):410-20
53. Chiam PTL, Abdullah F, Chow HK, et al. The ethnic characteristics and prevalence of
diabetes mellitus, hypertension and hyperlipidaemia in patients who underwent
coronary artery bypass grafting in Hospital Universiti Kebangsaan Malaysia. Med J
Malaysia 2002;57(4):460-6
54. Chin KH, Sathyasurya DR, Hazizi AS, et al. Effect of ethnicity, dietary intake and
physical activity on plasma adiponectin concentrations among malaysian patients
with type 2 diabetes mellitus. Int J Endocrinol Metab 2013;11(3):167-74
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3860115
55. Chin SP, Liew CK, Tay SP, et al. Platelet non-responsiveness to dual antiplatelet
therapy and relation to coronary disease among diabetes patients. Int J Cardiol
2007;118(3):418-20
56. Chin SP, Shahrin Tarmizi CA, How SH, et al. Do patients' understanding of diabetes
and perception of control predict higher HbA1c and complications? International
Medical Journal (IIUM) 2006;5(1)

57. Chong VHT, Tan CT, Goh KJ, et al. Occupational exposure, age, diabetes mellitus and
outcome of acute Nipah encephalitis. Neurology Journal of Southeast Asia 2001;6:711
http://www.neurology-asia.org/articles/20011_007.pdf
58. Chong YB, Keng TC, Tan LP, et al. Clinical predictors of non-diabetic renal disease and
role of renal biopsy in diabetic patients with renal involvement: a single centre
review. Ren Fail 2012;34(3):323-8
59. Choo KE, Lau KB, Davis WA, et al. Cardiovascular risk factors in pre-pubertal Malays:
effects of diabetic parentage. Diabetes Res Clin Pract 2007;76(1):119-25
60. Choo M, Prakash K, Amir S, et al. Corneal changes in type II diabetes mellitus in
Malaysia. Int J Ophthalmol 2010;3(3):234-6
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340640
61. Chuang LM, Soegondo S, Soewondo P, et al. Comparisons of the outcomes on control,
type of management and complications status in early onset and late onset type 2
diabetes in Asia. Diabetes Res Clin Pract 2006;71(2):146-55
62. Chuang LM, Tsai ST, Huang BY, et al. The status of diabetes control in Asia--a crosssectional survey of 24 317 patients with diabetes mellitus in 1998. Diabet Med
2002;19(12):978-85
63. Cliffton A, Md. Mizanur R, Mohd Syafiq A. The relevant intervention strategies for
improving medication adherence of diabetic patients. International Journal of Public
Health Research 2013;3(1):236
http://journalarticle.ukm.my/6132/1/vol_3_no_1_2013_31.pdf
64. Dhanjal TS, Lal M, Haynes R, et al. A comparison of cardiovascular risk factors among
Indo-Asian and caucasian patients admitted with acute myocardial infarction in Kuala
Lumpur, Malaysia and Birmingham, England. Int J Clin Pract 2001;55(10):665-8
65. Duong JK, Kumar SS, Kirkpatrick CM, et al. Population pharmacokinetics of metformin
in healthy subjects and patients with type 2 diabetes mellitus: simulation of doses
according to renal function. Clin Pharmacokinet 2013;52(5):373-84
66. Eid M, Mafauzy M, Faridah AR. Non-achievement of clinical targets in patients with
type 2 diabetes mellitus. Med J Malaysia 2004;59(2):177-84
http://www.e-mjm.org/2004/v59n2/Type_2_Diabetes_Mellitus.pdf
67. Eid M, Mafauzy M, Faridah AR. Dyslipidaemic pattern of patients with type 2 diabetes
mellitus. Malays J Med Sci 2004;11(1):44-51
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438150
68. Eid M, Mafauzy M, Faridah A. Glycaemic control of type 2 diabetic patients on follow
up at hospital universiti sains malaysia. Malays J Med Sci 2003;10(2):40-9
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3561886
69. Eid M, Mafauzy M, Faridah AR. Dyslipidaemia In patients with type 2 diabetes
mellitus. Journal of the ASEAN Federation of Endocrine Societies 2003;21(1/2):44-54.
70. Elfatih IE, Abdul Razak M, Mohamed Izham MI, et al. A survey of tuberculosis cases in
Penang Hospital: preliminary findings. Malaysian Journal of Pharmaceutical Sciences
2004;2(2):1-8
http://myais.fsktm.um.edu.my/6805/1/a_survey_vol2_no2_(1-8)2004.PDF;
http://www.pha.usm.my/pharmacy/Webpage%20journal/abstract/2.2-1.pdf
71. Eppens MC, Craig ME, Jones TW, et al. Type 2 diabetes in youth from the Western
Pacific region: glycaemic control, diabetes care and complications. Curr Med Res Opin
2006;22(5):1013-20
72. ESRD Incidence Study Group, Stewart JH, McCredie MR, et al. Geographic, ethnic,
age-related and temporal variation in the incidence of end-stage renal disease in
Europe, Canada and the Asia-Pacific region, 1998-2002. Nephrol Dial Transplant
2006;21(8):2178-83

73. Etemad A, Ramachandran V, Pishva SR, et al. Analysis of Gln223Agr polymorphism of


Leptin Receptor Gene in type II diabetic mellitus subjects among Malaysians. Int J Mol
Sci 2013;14(9):19230-44
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794830
74. Foo SH, Chan SP, Shaiful Bahari I, et al. Insulin resistance is the predominant
pathophysiologic feature of hyperglycemia in newly diagnosed overweight and obese
type 2 diabetes mellitus in two university hospitals in Malaysia. Journal of the ASEAN
Federation of Endocrine Societies 2012;26(2):143-9
http://www.asean-endocrinejournal.org/images/ISSUE2/oa-insulin%20resistance%20%20malaysia.pdf
75. Foo SM, Wong HS, Zaki Morad MZ. Risk factors and incidence of posttransplant
diabetes mellitus in renal transplant recipients. Transplant Proc 2004;36(7):2139-40
76. Fuziah MZ, Hong JY, Zanariah H, et al. A national database on children and adolescent
with diabetes (e-DiCARE): results from April 2006 to June 2007. Med J Malaysia
2008;63 Suppl C:37-40
77. G. R. Letchuman R, Wan Nazaimoon WM, Wan Mohamad WB, et al. Prevalence of
diabetes in the Malaysian National Health Morbidity Survey III 2006. Med J Malaysia
2010;65(3):180-6
http://www.e-mjm.org/2010/v65n3/Diabetes.pdf
78. Ghani RA, Bin Yaakob I, Wahab NA, et al. The influence of fenofibrate on lipid profile,
endothelial dysfunction, and inflammatory markers in type 2 diabetes mellitus
patients with typical and mixed dyslipidemia. J Clin Lipidol 2013;7(5):446-53
79. Gillani SW, Syed Azhar SS, Sari YO, et al. Perceived Stress Scale psychometric
validation for Malaysian diabetic patients. British Journal of Pharmaceutical Research
2011;1(4):156-63
http://zenodo.org/record/8643/files/1319340970-WasifSayed_2011BJPR511.pdf
80. Gillani SW, Syed Azhar SS, Suzana CV, et al. Applicability of pharmaceutical care in
endocrine clinic of Hospital Penang, Malaysia. Journal of Diabetes Research and
Clinical Metabolism 2012;1(1):11
http://www.hoajonline.com/journals/pdf/2050-0866-1-11.pdf
81. Go KW, Teo SM, Hasniza AH. Efficacy and safety of oral hypoglycaemic agents in the
treatment of diabetes mellitus in patients with end stage renal failure on dialysis.
Medical Practice Hospital Ipoh 2003;6(2):5-8
82. Goldhaber-Fiebert JD, Li H, Ratanawijitrasin S, et al. Inpatient treatment of diabetic
patients in Asia: evidence from India, China, Thailand and Malaysia. Diabet Med
2010;27(1):101-8
83. Hamidon B, Nabil I, Raymond AA. Risk factors and outcome of dysphagia after an
acute ischaemic stroke. Med J Malaysia 2006;61(5):553-7
http://www.e-mjm.org/2006/v61n5/Acute_Ischaemic_Stroke.pdf
84. Hamidon B, Raymond AA. The impact of diabetes mellitus on in-hospital stroke
mortality. J Postgrad Med 2003;49(4):307,9; discussion 309-10
85. Hamidon B, Raymond AA. Predictors of in-hospital mortality after an acute ischaemic
stroke. Neurology Journal of Southeast Asia 2003;8:5-8
http://www.neurology-asia.org/articles/20031_005.pdf
86. Hanifullah K. A call to arms clear the confusion. Journal of Endocrinology and
Metabolism 2013;3(1):24-8
http://www.jmems.org/index.php/jmems/article/view/74/58
87. Hapizah MN, Musilawati M, Yeo CK, et al. Type of diabetes and waist-hip ratio are
important determinants of serum lipoprotein (a) levels in diabetic patients. Diabetes
Res Clin Pract 2002;56(3):221-7

88. Hasan SS, Syed Imran A, Nadeem Irfan B, et al. Use of complementary and
alternative medicine among patients with chronic diseases at outpatient clinics.
Complement Ther Clin Pract 2009;15(3):152-7
89. Hasan SS, Ahmadi K, Santigo R, et al. The validity of the menopause-specific quality
of life questionnaire in women with type 2 diabetes. Climacteric 2013;.
90. Hasnan J, Mohd Imran Y, Damitri TD, et al. Relationship between apoptotic markers
(Bax and Bcl-2) and biochemical markers in type 2 diabetes mellitus. Singapore Med J
2010;51(1):50-5
http://smj.sma.org.sg/5101/5101a7.pdf
91. Hasniza ZH, Lee CL. Drug-related problems in type 2 diabetes mellitus patients with
dyslipidemia. BMC Public Health 2013;13:1192,2458-13-1192
http://www.biomedcentral.com/content/pdf/1471-2458-13-1192.pdf
92. Hasniza ZH, Wee HF. Drug related problems in type 2 diabetes patients with
hypertension: a cross-sectional retrospective study. BMC Endocr Disord
2013;13:2,6823-13-2
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3542270
93. Hasniza ZH, Yeap SM, Rokiah P. Episodes of hypoglycemia and hyperglycemia during
the use of sliding scale insulin in hospitalized diabetes patients. Asian Biomedicine
2007;1(3):307-11
http://abm.digitaljournals.org/index.php/abm/article/viewFile/133/52
94. Hasniza ZH, Tan G,Kuan Foong, Rokiah P, et al. Different characteristics of diabetic
ketoacidosis between type 1 and type 2 diabetes patients in Malaysia. Asian
Biomedicine 2009;3(2):201-5
http://abm.digitaljournals.org/index.php/abm/article/viewFile/446/327
95. Hasniza ZH, Ong CW, Rokiah P. Self-monitoring of blood glucose among type-2
diabetes patients in Malaysia. Asian Biomedicine 2008;2(4):335-40
http://abm.digitaljournals.org/index.php/abm/article/viewFile/198/117
96. Hassan SA, Rahman RA, Huda N, et al. Hospital-acquired Clostridium difficile infection
among patients with type 2 diabetes mellitus in acute medical wards. J R Coll
Physicians Edinb 2013;43(2):103-7
97. Hayati AR, Cheah FC, Tan AE, et al. Insulin-like growth factor-1 receptor expression in
the placentae of diabetic and normal pregnancies. Early Hum Dev 2007;83(1):41-6
98. Hayati AR, Cheah FC, Yong JF, et al. The role of serum insulin-like growth factor I (IGFI) in neonatal outcome. J Clin Pathol 2004;57(12):1299-301
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1770509
99. Hazizi AS, Zaitun MY, Mirnalini K, et al. Glycaemic control, lipid profile, blood pressure
and body weight status among diabetics in rural Malaysia. International Medical
Journal (IIUM) 2007;8(2):21-8
http://iiumedic.net/imjm/v1/download/Volume%2008%20No%202/IMJVol8No2pg2128.pdf
100.
Hidayah NI, Che Muhaya M, Hanizah Y, et al. Risk factors for low vision
amongst individuals aged 40 years and above in the subdistrict of Beranang, Hulu
Langat, Selangor. International Medical Research Journal 2001;5(1):13-6
101.
Home PD, Latif ZA, Gonzalez-Galvez G, et al. The effectiveness and safety of
beginning insulin aspart together with basal insulin in people with type 2 diabetes in
non-Western nations: results from the A(1)chieve observational study. Diabetes Res
Clin Pract 2013;101(3):326-32
http://www.diabetesresearchclinicalpractice.com/article/S0168-8227(13)00231-3/pdf
102.
Ibrahim SS, baougalambou ASI, Rahmawati F, et al. Prevalence and control of
hypertension among diabetes patients in Hospital Universiti Sains Malaysia, Malaysia.
Majalah Farmasi Indonesia 2010;21(2):121-8

103.
Ikram Shah I, Wan Nazaimoon WM, Wan Mohamad WB, et al. Ethnicity and
glycaemic control are major determinants of diabetic dyslipidaemia in Malaysia.
Diabet Med 2001;18(6):501-8
http://umexpert.um.edu.my/file/publication/00000559_30514.pdf
104.
Ikram Shah I, Wan Nazaimoon WM, Wan Mohamad WB, et al.
Sociodemographic determinants of glycaemic control in young diabetic patients in
peninsular Malaysia. Diabetes Res Clin Pract 2000;47(1):57-69
105.
Indran M, Rokiah P, Chan SP, et al. Alteration of lipid peroxidation and
antioxidant enzymes in young Malaysian IDDM patients. Med J Malaysia
2004;59(2):166-70
http://www.e-mjm.org/2004/v59n2/Lipid_Peroxidation_Antioxidant_Enzymes.pdf.
106.
Ismail MN, Chee WSS, Nawawi H, et al. Obesity in Malaysia. Obes Rev
2002;3(3):203-8
http://site.ppk.com.my/Clients/ppkcommy/obesity_and_metabolic_risk_in_asians.pdf
107.
Jamsiah M, Zurainatul Irwani I, Sharifa Ezat WP, et al. Stress among diabetic
mellitus patients with complication at Raja Perempuan Zainab II Hospital, Kota Bharu,
Kelantan. Jurnal Kesihatan Masyarakat 2009;15(1):39-46
http://journalarticle.ukm.my/4622/1/Vol15(1)-azimatun.pdf
108.
Juwita S, Suraya M, Nor Azwany Y. Awareness of correct blood glucose target
among type 2 diabetic mellitus patient attending diabetic centre of tertiary hospital.
International Journal of Collaborative Research on Internal Medicine & Public Health
2012;4(12):1923-31
http://www.iomcworld.com/ijcrimph/files/v04-n12-07.pdf.
109.
Kalra S, Plata-Que T, Kumar D, et al. Initiation with once-daily BIAsp 30 results
in superior outcome compared to insulin glargine in Asians with type 2 diabetes
inadequately controlled by oral anti-diabetic drugs. Diabetes Res Clin Pract
2010;88(3):282-8
110.
Kamarul Imran M, Ismail AA, Naing L, et al. The reliability and validity of the
Malay version of the 18-item audit of Diabetes Dependent Quality of Life (the Malay
ADDQOL) questionnaire. Southeast Asian J Trop Med Public Health 2007;38(2):398405
111.
Kee CC, Yusoff hF, Sumarni MG, et al. Optimal BMI cut-off values for predicting
diabetes, hypertension and hypercholesterolaemia in a multi-ethnic population.
Public Health Nutr 2013;16(3):453-9
http://journals.cambridge.org/download.php?file=%2FPHN
%2FPHN16_03%2FS1368980012002911a.pdf&code=49f9a158f8ba297da22b52fd9ff5
084a.
112.
Khaled AA, Sekaran M, Ikram Shah I. Role of N-(carboxymethyl)lysine in the
development of ischemic heart disease in type 2 diabetes mellitus. J Clin Biochem
Nutr 2007;41(2):97-105
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2170948
113.
Khalid AK, Wan Nazaimoon WN. The spread of diabetes mellitus in South-East
Asia. Journal of the ASEAN Federation of Endocrine Societies 2001;19(1):14-9
114.
Koay CB, Mohd Zabri Affendi M, Moissinac K. Comparison of olfactory acuity in
diabetic and non-diabetic patients and using Alcohol Sniff Olfactory Test (ASOT) and
University of Pennsylvania Smell Identification Test (UPSIT). International Medical
Research Journal 2000;4(1).
115.
Koo H, Daniel Robert S, Hamid Jan JM. Which is a better anthropometric
indicator of cardiovascular risk factors in type 2 diabetes mellitus patients? Waist hip
ratio or body mass index? Malays J Nutr 2013;19(2):163-72
http://nutriweb.org.my/publications/mjn0019_2/2%20Hamid%20_418(edSP)(RV)SP.pdf

116.
Kulenthran A, Abdul Majeed N. Glycated haemoglobin is a good predictor of
neonatal hypoglycaemia in pregnancies complicated by diabetes. Malays J Pathol
2011;33(1):21-4
http://www.mjpath.org.my/2011.1/Glycated_haemoglobin.pdf
117.
Kuppusamy UR, Indran M, Rokiah P. Glycaemic control in relation to xanthine
oxidase and antioxidant indices in Malaysian type 2 diabetes patients. Diabet Med
2005;22(10):1343-6
118.
Kuppusamy UR, Indran M, Tsara A, et al. Comparison of oxidative damage in
Malaysian end-stage renal disease patients with or without non-insulin-dependent
diabetes mellitus. Clin Chim Acta 2005;351(1-2):197-201
119.
Lai PSM, Chua SS, Tan CH, et al. Validation of the diabetes, hypertension and
hyperlipidemia (DHL) knowledge instrument in Malaysia. BMC Med Res Methodol
2012;12:18,2288-12-18
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352255
120.
Lai SY, Yahaya H, Noorizan AA, et al. A comparison of knowledge of diabetes
mellitus between patients with diabetes and healthy adults: a survey from north
Malaysia. Patient Educ Couns 2007;69(1-3):47-54
121.
Lai LC. Prevention of type 2 diabetes. Malays J Pathol 2002;24(2):71-6
http://www.mjpath.org.my/past_issue/MJP2002.2/Prevention%20of%20type
%202%20Diabetes.pdf
122.
Latiffah AL, Nor Afiah MZ, Nor Amalina E, et al. Prevalence of diseases among
elderly admitted to a tertiary hospital in Malaysia 2002. International Medical Journal
(IIUM) 2006;5(1).
123.
Lau CH, Sekaran M. Novel adiponectin-resistin (AR) and insulin resistance
(IRAR) indexes are useful integrated diagnostic biomarkers for insulin resistance, type
2 diabetes and metabolic syndrome: a case control study. Cardiovasc Diabetol
2011;10(1):8
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3036610/pdf
124.
Lee PY, Lee YK, Khoo EM, et al. How do health care professionals assess
patients when initiating insulin therapy? A qualitative study. Prim Care Diabetes
2014;8(1):49-55
125.
Lee YK, Lee PY, Ng CJ. Tactics in counselling patients to start insulin. Diabet
Med 2013;30(3):373-4
126.
Lee YK, Low WY, Ng CJ. Exploring patient values in medical decision making: a
qualitative study. PLoS One 2013;8(11):e80051
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839918
127.
Lee YY, Tee MH, Zurkurnai Y, et al. Thrombolytic failure with streptokinase in
acute myocardial infarction using electrocardiogram criteria. Singapore Med J
2008;49(4):304-10
http://smj.sma.org.sg/4904/4904a5.pdf
128.
Lee YK, Low WY, Lee PY, et al. Factors influencing decision-making role
preferences: A qualitative study of Malaysian patients with type 2 diabetes during
insulin initiation. Int J Nurs Pract 2014
129.
Li YY, Wang XM, Lu XZ. KCNQ1 rs2237892 C-->T gene polymorphism and type
2 diabetes mellitus in the Asian population: a meta-analysis of 15,736 patients. J Cell
Mol Med 2014;18(2):274-82
130.
Lim TO, Rugayah B, Maimunah AH. Familial aggregation and determinants of
post challenge blood glucose in four ethnic populations. Med J Malaysia
2004;59(3):357-71
http://www.e-mjm.org/2004/v59n3/Familial_Aggregation.pdf

131.
Lim TO, Rugayah B, Zaki Morad MZ, et al. Bimodality in blood glucose
distribution: is it universal? Diabetes Care 2002;25(12):2212-7
http://care.diabetesjournals.org/content/25/12/2212.full.pdf+html
132.
Lim TO, Ding LM, Zaki Morad MZ, et al. Clustering of hypertension, abnormal
glucose tolerance, hypercholesterolaemia and obesity in Malaysian adult population.
Med J Malaysia 2000;55(2):196-208
http://www.e-mjm.org/2000/v55n2/Hypertension.pdf
133.
Lim PC, Lim SL, Oiyammaal C. Glycaemic control and cost analysis when
changing from gliclazide co-administered with metformin to pre-combined
glibenclamide-metformin tablets in type 2 diabetes mellitus. Med J Malaysia
2012;67(1):21-4
http://www.e-mjm.org/2012/v67n1/Glibenclamide-Metformin.pdf
134.
Lim SL, Soh KP, Kuppusamy UR. Effects of naringenin on lipogenesis, lipolysis
and glucose uptake in rat adipocyte primary culture: a natural antidiabetic agent.
Internet Journal of Alternative Medicine 2008;5(2). https://ispub.com/IJAM/5/2/11973
135.
Lim-Abrahan MA, Jain AB, Wan Mohamad WB, et al. Safety and effectiveness of
biphasic insulin aspart 30 in type 2 diabetes: results from the ASEAN cohort of the
A(1)chieve study. Diabetes Res Clin Pract 2013;100 Suppl 1:S3-9
136.
Linjawi S, Radhakrishna S, Sari R, et al. The study of once- and twice-daily
biphasic insulin aspart 30 (BIAsp 30) with sitagliptin, and twice-daily BIAsp 30 without
sitagliptin, in patients with type 2 diabetes uncontrolled on sitagliptin and metforminThe Sit2Mix trial. Prim Care Diabetes 2014
137.
Lock LT, Tzanakakis ES. Scalable production of pancreatic islet progenitors for
diabetes cell therapies. Med J Malaysia 2008;63 Suppl A:5-6
138.
Loh BI, Sathyasuryan DR, Hamid Jan JM. Plasma adiponectin concentrations
are associated with dietary glycemic index in Malaysian patients with type 2
diabetes. Asia Pac J Clin Nutr 2013;22(2):241-8
http://apjcn.nhri.org.tw/server/APJCN/22/2/241.pdf
139.
Loke SC, Rahim KF, Kanesvaran R, et al. A prospective cohort study on the
effect of various risk factors on hypoglycaemia in diabetics who fast during Ramadan.
Med J Malaysia 2010;65(1):3-6
http://www.e-mjm.org/2010/v65n1/Hypoglycaemia_in_Diabetics.pdf
140.
Loke SC, Jong M. Metabolic control in type 2 diabetes correlates weakly with
patient adherence to oral hypoglycaemic treatment. Ann Acad Med Singapore
2008;37(1):15-20
.
141.
Loo KW, Griffiths LR, Gan SH. A sweet promise among Malaysians: Diabetes in
Malaysia. J Diabetes 2014;.
142.
Mafauzy M, Zanariah H, Chan SP. The status of diabetes control in Malaysia:
results of DiabCare 2008. Med J Malaysia 2011;66(3):175-81
http://www.e-mjm.org/2011/v66n3/Diabetes_Control.pdf
143.
Mafauzy M, Diabcare-Asia 2003 Study Group. An audit on diabetes
management in Asian patients treated by specialists: the Diabcare-Asia 1998 and
2003 studies. Curr Med Res Opin 2008;24(2):507-14
144.
Mafauzy M. Diabetes control and complications in public hospitals in Malaysia.
Med J Malaysia 2006;61(4):477-83
http://www.e-mjm.org/2006/v61n4/Diabetes_Control_Complications.pdf
145.
Mafauzy M, Winn T, Rampal L, et al. A prelimenary result of the cardiovascular
risk factors intervention study (Pikom Study): diabetes mellitus, hypertension and
their associated factors. Malays J Med Sci 2005;12(1):20-5
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349409

146.
Mafauzy M, Mokhtar N, Wan Mohamad WB. Hypertension and associated
cardiovascular risk factors in Kelantan. Med J Malaysia 2003;58(4):556-64
http://www.e-mjm.org/2003/v58n4/Hypertension.pdf
147.
Mafauzy M. Repaglinide versus glibenclamide treatment of Type 2 diabetes
during Ramadan fasting. Diabetes Res Clin Pract 2002;58(1):45-53
148.
Marre M, Shaw J, Brandle M, et al. Liraglutide, a once-daily human GLP-1
analogue, added to a sulphonylurea over 26 weeks produces greater improvements
in glycaemic and weight control compared with adding rosiglitazone or placebo in
subjects with type 2 diabetes (LEAD-1 SU). Diabet Med 2009;26(3):268-78
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2871176
149.
Mastura I, Zanariah H, Fatanah I, et al. An Audit of Diabetes Control and
Management (ADCM). Med J Malaysia 2008;63 Suppl C:76-7
150.
Mastura I. Core competencies in diabetes care: educating health professionals
as diabetes educators. NCD Malaysia 2005;4(2):2-3
151.
Md Yazid J, Fuziah MZ, Hadhrami M, et al. Reliability and validity of the Malay
translated version of diabetes quality of life for youth questionnaire. Malaysian
Family Physician 2013;8(1):12-9
http://www.e-mfp.org/2013v8n1/diabetes-quality-of-life.pdf
152.
Md Yazid J, Fuziah MZ, Hong JYH, et al. Reliability and validity of the revised
summary of diabetes self-care activities (SDSCA) for Malaysian children and
adolescents. Malaysian Family Physician 2012;7(2&3):10-20
http://www.e-mfp.org/old/2012v7n2_3/Diabetes-Self-Care-Activities.pdf
153.
Minas H, Ruzanna ZZ, Marhani M, et al. Attitudes of Malaysian general hospital
staff towards patients with mental illness and diabetes. BMC Public Health
2011;11:317,2458-11-317
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112131
154.
Mohamed EAH, Mohammad Jamshed AS, Ang LF, et al. Potent alphaglucosidase and alpha-amylase inhibitory activities of standardized 50% ethanolic
extracts and sinensetin from Orthosiphon stamineus Benth as anti-diabetic
mechanism. BMC Complement Altern Med 2012;12:176,6882-12-176
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533584/pdf/1472-6882-12-176.pdf
155.
Mohammad Yousuf R, Humairah-Cheung AS. A diabetic patient with sudden
periorbital swelling and proptosis. International Medical Journal (IIUM) 2003;2(2).
156.
Mohammad Yousuf R, Fauzi ARM, How SH, et al. Metabolic changes during
Ramadan fasting in normal people and diabetic patients. International Medical
Journal (IIUM) 2003;2(2).
157.
Mohd Amin Bujang, Puzziawati Abdul Ghani, Nur Amirah Zolkepali, Sharmini
Selvarajah and Jamaiyah Haniff. A comparison between convenience sampling versus
systematic sampling in getting the true parameter in a population: Explore from a
clinical database: The Audit Diabetes Control Management (ADCM) registry in
2009International Conference on Statistics in Science, Business, and Engineering
(ICSSBE) 2012201210-12 Sept;LangkawiIEEE;2012.
158.
Moy FM, Awang Bulgiba AM. The modified NCEP ATP III criteria maybe better
than the IDF criteria in diagnosing Metabolic Syndrome among Malays in Kuala
Lumpur. BMC Public Health 2010;10:678,2458-10-678
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2989964
159.
Moy FM, Hoe VCW, Tan CPL, et al. Cardiovascular risks among shift and nonshift workers in a public medical centre in Kuala Lumpur. JUMMEC 2010;13(1):45-9
http://jummec.um.edu.my/filebank/published_article/3155/JUMMEC
%202010%2013(1)%2045-49.pdf

160.
Moy FM, Atiya AS, Wong ML. The results of a worksite health promotion
programme in Kuala Lumpur, Malaysia. Health Promot Int 2006;21(4):301-10
http://heapro.oxfordjournals.org/content/21/4/301.full.pdf
161.
Muhammad RA H, Subhada PP, Ng PP, et al. Incidence, risk factors and clinical
epidemiology of melioidosis: a complex socio-ecological emerging infectious disease
in the Alor Setar region of Kedah, Malaysia. BMC Infect Dis 2010;10:302,2334-10-302
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2975659
162.
Muhammad K, Al-Jamal HAN, Narazah MY. Association of ABO blood groups
with diabetes mellitus. Libyan J Med
2010;5http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071167
163.
Nadzimah MN, Thevarajah M, Chew YY. Hemoglobin variants detected by
hemoglobin A1c (HbA1c) analysis and the effects on HbA1c measurements. Int J
Diabetes Dev Ctries 2010;30(2):86-90
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878696
164.
Naing C, Mak JW, Syed Imran A, et al. Relationship between hepatitis C virus
infection and type 2 diabetes mellitus: meta-analysis. World J Gastroenterol
2012;18(14):1642-51
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325531/pdf/WJG-18-1642.pdf.
165.
Nawawi H, Sazali BS, Kamaruzaman BH, et al. Effect of ambient temperature
on analytical and clinical performance of a blood glucose monitoring system:
Omnitest Sensor glucose meter. Ann Clin Biochem 2001;38(Pt 6):676-83
166.
Nazratun N, Mahmood AA, Kuppusamy UR, et al. Diabetes mellitus
exacerbates advanced glycation end product accumulation in the veins of end-stage
renal failure patients. Vasc Med 2006;11(4):245-50
167.
Nazri M, Suhairi I, Wan Zaidah A, et al. Add-on rosiglitazone therapy improves
plasminogen activity and high-density lipoprotein cholesterol in type 2 diabetes
mellitus. Blood Coagul Fibrinolysis 2011;22(6):512-20
168.
Ng SH, Chan KH, Lian ZY, et al. Reality vs illusion: Knowledge, attitude and
practice among diabetic patients. International Journal of Collaborative Research on
Internal Medicine & Public Health 2012;4(5):723-32
http://www.iomcworld.com/ijcrimph/files/v04-n05-33.pdf
169.
Ng TK. Prevalence of depression among diabetic patients in an outpatient
clinic in Hospital Sik: A rural hospital in Malaysia. Asian J Psychiatr 2010;3(2):76-7
170.
Nirmala K, Hanis A, Izzat H, et al. Outcome of pregnancy among Malaysian
women with diabetes mellitus - a single centre experience. Malaysian Journal of
Public Health Medicine 2013;13(2):1-10
http://www.mjphm.org.my/mjphm/journals/volume%2013%20(2)/OUTCOME%20OF
%20PREGNANCY%20AMONG%20MALAYSIAN%20WOMEN%20WITH%20DIABETES
%20MELLITUS%20-%20A%20SINGLE%20CENTRE%20EXPERIENCE.pdf
171.
Nissapatorn V, Kuppusamy I, Josephine FP, et al. Tuberculosis: a resurgent
disease in immunosuppressed patients. Southeast Asian J Trop Med Public Health
2006;37 Suppl 3:153-60
http://www.tm.mahidol.ac.th/seameo/2006_37_spp3/37sup3_153.pdf
172.
Nissapatorn V, Kuppusamy I, Sim BL, et al. Pulmonary tuberculosis in a
hospital setting: gender differences. Public Health 2006;120(5):441-3
173.
Nissapatorn V, Kuppusamy I, Jamaiah I, et al. Tuberculosis in diabetic patients:
a clinical perspective. Southeast Asian J Trop Med Public Health 2005;36 Suppl 4:21320
http://www.tm.mahidol.ac.th/seameo/2005_36_spp4/36sup4_213.pdf
174.
Noor Hasimah M, Nurhanani M, Ramli M. Medical complications among type 2
diabetes mellitus patients at a general hospital in east coast Malaysia. International
Medical Journal (IIUM) 2010;9(1):15-20

http://iiumedic.net/imjm/v1/download/Volume%2009%20No%201/eIMJVol9No1_pg1520.pdf
175.
Nor Azwany Y, Abdul Aziz al-Safi I, Wan Mohamad WB. Knowledge, attitude,
and practice of type 2 diabetes mellitus patients on Ramadan fasting at Hospital
Universiti Sains Malaysia. Journal of the Islamic Medical Association of North America
2007;39(1):6-12
http://jima.imana.org/article/view/5253/3609
176.
Nor Hayati O, Anani Aila MZ. Association of colorectal carcinoma with
metabolic diseases; experience with 138 cases from Kelantan, Malaysia. Asian Pac J
Cancer Prev 2008;9(4):747-51
http://www.apocpcontrol.org/paper_file/issue_abs/Volume9_No4/747%20c
%20Othman.pdf
177.
Nor Hayati O, Zaini MN, Biswal BM. Is Kelantan joining the global cancer
epidemic?--experience from hospital Universiti Sains Malaysia; 1987-2007. Asian Pac
J Cancer Prev 2008;9(3):473-8
http://www.apocpcontrol.org/paper_file/issue_abs/Volume9_No3/473%20Othman
%20.pdf
178.
Norbanee THT, Kamaliah MD, Ismail AA. Prevalence and risk factors for
microalbuminuria in patients with type 2 diabetes mellitus in north-east Malaysia.
International Medical Journal (Tokyo) 2003;10:261-6
179.
Norhafizah S, Siti Zuraidah M, Saari R, et al. Medication labeling literacy
among Malaysian with diabetes: a cross-sectional study. Journal of Diabetes Research
and Clinical Metabolism 2012;1(1):23
http://www.hoajonline.com/journals/pdf/2050-0866-1-23.pdf
180.
Norhayati Y, Kyi WM, Norhayati MN, et al. Type 2 diabetes with good glycemic
control have improved insulin response and lower non-esterified fatty acid level after
a meal challenge. Journal of Diabetes Mellitus 2012;2:1
http://www.scirp.org/journal/PaperDownload.aspx?
FileName=JDM20120100025_14655500.pdf&paperID=17284.
181.
Norlaila M, Nor Azmi K, Abdul Aziz I, et al. Prevalence of abnormal glucose
tolerance and risk factors in urban and rural Malaysia. Diabetes Care
2011;34(6):1362-4
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114358
182.
Norlaili M, Bakiah S, Zunaina E. Intravitreal triamcinolone versus laser
photocoagulation as a primary treatment for diabetic macular oedema--a
comparative pilot study. BMC Ophthalmol 2011;11:36,2415-11-36
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3231950
183.
Norlinah MI, Hamizah R, Siti Harnida MI, et al. The effects of short-term, rapid
glycemic control on the peroneal nerve function and serum VCAM-1 and AGE in type
2 diabetic patients in Malaysia. Indian J Med Sci 2009;63(4):131-8
http://www.bioline.org.br/pdf?ms09027.
184.
Ong HT. The statin studies: from targeting hypercholesterolaemia to targeting
the high-risk patient. QJM 2005;98(8):599-614
http://qjmed.oxfordjournals.org/content/98/8/599.full.pdf.
185.
Ong LM, Punithavathi N, Dharminy T, et al. Prevalence and risk factors for
proteinuria: the National Kidney Foundation of Malaysia Lifecheck Health Screening
programme. Nephrology (Carlton) 2013;18(8):569-75
186.
Ong MJ, Mohammadreza P, Tan CC, et al. Risk factors for clinically significant
macular edema in a multi-ethnics population with type 2 diabetes. Int J Ophthalmol
2012;5(4):499-504
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428549

187.
Ooi CG, Haizee HN, Kando DV, et al. Diabetes mellitus in a Malaysian teaching
hospital: prevalence of diabetes mellitus and frequency of testing for
hypercholesterolaemia, proteinuria and HbA1c. Med J Malaysia 2002;57(2):195-200
http://www.e-mjm.org/2002/v57n2/Diabetes_Mellitus.pdf
188.
Oteh M, Shah Azarisman SM, Azreen SA, et al. Institutional hypertension
control in Malaysia: a multicenter study focusing on gender and cardiovascular risk
factor profile difference. Hypertens Res 2011;34(3):319-24
189.
Pan CY, So WY, Khalid AK, et al. Metabolic, immunological and clinical
characteristics in newly diagnosed Asian diabetes patients aged 12-40 years. Diabet
Med 2004;21(9):1007-13
190.
Pathak R, Pathak A. Study of life style habits on risk of type 2 diabetes. Int J
Appl Basic Med Res 2012;2(2):92-6
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678701
191.
Patil SS, Hasamnis AA, Narayan KA, et al. A household drug utilization survey
among diabetics in rural Malaysia. Int J Diabetes Dev Ctries 2010;30(4):231-2
http://www.rssdi.in/diabetesbulletin/2010/OCTOBER/IntJDiabDevCtries3042318359286_021919.pdf
192.
Pavai S, Chan SP. Urinary type IV collagen levels in diabetes mellitus. Malays J
Pathol 2010;32(1):43-7
http://www.mjpath.org.my/2010.1/Urinary_type_IV_collagen.pdf
193.
Poh R, Muniandy S. Paraoxonase 1 activity as a predictor of cardiovascular
disease in type 2 diabetes. Southeast Asian J Trop Med Public Health
2010;41(5):1231-46
194.
Poh R, Muniandy S. Ethnic variations in paraoxonase1 polymorphism in the
Malaysian population. Southeast Asian J Trop Med Public Health 2007;38(2):392-7
195.
Purnami SW, Abdullah E, Jasni MZ, et al. A new smooth support vector
machine and its applications in diabetes disease diagnosis. Journal of Computer
Science 2009;5(12):1003-8
http://thescipub.com/PDF/jcssp.2009.1003.1008.pdf
196.
Puthucheary SD, Nathan SA. Comparison of serum F2 isoprostane levels in
diabetic patients and diabetic patients infected with Burkholderia pseudomallei.
Singapore Med J 2008;49(2):117-20
http://smj.sma.org.sg/4902/4902a5.pdf
197.
Qvist R, Ikram Shah I, Sekaran M, et al. Sialic acid and vascular cell adhesion
molecule-1 as early markers in the first degree relatives of type 2 diabetes meUitus
patients. Journal of Medical Sciences 2006;6(2):235-40
http://198.170.104.138/jms/2006/235-240.pdf
198.
Qvist R, Ikram Shah I, Muniandy S, et al. Plasma sialic acid levels in the
offspring of one parent with type 2 diabetes mellitus. Biomedical Research
2005;16(3):213-7
http://www.biomedres.org/journal/pdf/114.pdf;http://eprints.um.edu.my/7225/1/plasm
a_sialic_acid_levels.pdf
199.
Qvist R, Ismail IS, Karuthan C, et al. Use of glycated hemoglobin (HbA(1C))
and impaired glucose tolerance in the screening of undiagnosed diabetes in the
Malaysian population. Indian J Clin Biochem 2008;23(3):246-9
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3453455
200.
Rafidah Hanim M, Azizi A, Noriah MN. Blood pressure variability in patients
with diabetes mellitus. Asian Cardiovasc Thorac Ann 2010;18(4):344-8
201.
Rahmah MA, Noraishah J. Elderly diabetic patients perception on family
support and glucose control. International Journal of Public Health Research
2011;1(1):7

202.
Rajakumar MK. Preventing diabetes: The task of the family doctor. Asia Pac
Fam Med 2003;2(1):8-9
http://www.apfmj-archive.com/afm2.1/afm_027.pdf
203.
Rajendra Acharya U, Faust O, Nahrizul Adib K, et al. Automated identification
of normal and diabetes heart rate signals using nonlinear measures. Comput Biol
Med 2013;43(10):1523-9
204.
Ramachandran V, Ismail P, Stanslas J, et al. Analysis of renin-angiotensin
aldosterone system gene polymorphisms in Malaysian essential hypertensive and
type 2 diabetic subjects. Cardiovasc Diabetol 2009;8:11,2840-8-11
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656464
205.
Ramachandran V, Ismail P, Stanslas J, et al. Association of insertion/deletion
polymorphism of angiotensin-converting enzyme gene with essential hypertension
and type 2 diabetes mellitus in Malaysian subjects. J Renin Angiotensin Aldosterone
Syst 2008;9(4):208-14
http://jra.sagepub.com/content/9/4/208.long.
206.
Ramadas A, Quek KF, Chan CK, et al. Randomised-controlled trial of a webbased dietary intervention for patients with type 2 diabetes mellitus: study protocol
of myDIDeA. BMC Public Health 2011;11:359,2458-11-359
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123593
207.
Rampal S, Rampal L, Ramlee R, et al. Variation in the prevalence, awareness,
and control of diabetes in a multiethnic population: a nationwide population study in
Malaysia. Asia Pac J Public Health 2010;22(2):194-202
208.
Reddy SC, Tajunisah I, Low KP, et al. Prevalence of eye diseases and visual
impairment in urban population - A study from University of Malaya Medical Centre.
Malaysian Family Physician 2008;3(1):25-8
http://www.e-mfp.org/old/2008v3n1/pdf/prevalence_eye_diseases.pdf
209.
Renukanth PCR, Taiyeb-Ali TB, Chan SP, et al. Effect of nonsurgical periodontal
therapy verses oral hygiene instructions on type 2 diabetes subjects with chronic
periodontitis: a randomised clinical trial. BMC Oral Health 2014;14:79,6831-14-79
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082680
210.
Reutens AT, Hutchinson R, Van Binh T, et al. The GIANT study, a clusterrandomised controlled trial of efficacy of education of doctors about type 2 diabetes
mellitus management guidelines in primary care practice. Diabetes Res Clin Pract
2012;98(1):38-45
211.
Roach VJ, Hin LY, Tam WH, et al. The incidence of pregnancy-induced
hypertension among patients with carbohydrate intolerance. Hypertens Pregnancy
2000;19(2):183-9
212.
Rokiah O, Knight VF, Zainora M. The causes of low vision and pattern of
prescribing at UKM Low Vision Clinic. Jurnal Sains Kesihatan Malaysia 2008;6(2):55-64
http://www.fskb.ukm.my/jurnal/jilid%206(2)2008/Chap%206.pdf
213.
Roshana M, Azidah AK, Lili Husniati Y. A study on depression among patient
with type 2 diabetes mellitus in north-east coast Malaysia. International Journal of
Collaborative Research on Internal Medicine & Public Health 2012;4(8):1589-600
http://www.iomcworld.com/ijcrimph/files/v04-n08-10.pdf
214.
Rothan HA, Suhaeb AM, Tunku Kamarul. Recombinant human adiponectin as a
potential protein for treating diabetic tendinopathy promotes tenocyte progenitor
cells proliferation and tenogenic differentiation in vitro. Int J Med Sci
2013;10(13):1899-906
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3856381
215.
Ruziana Mona, Wan Mohd Zin, Zati Iwani AK, Tuan Rosidah TS, et al.
Haemoglobin A1c: comparing performance of two point of care devices with

laboratory analyser. BMC Res Notes 2013;6:540,0500-6-540


http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878320
216.
Safiah Mokhtar S, M Vanhoutte P, W S Leung S, et al. Reduced expression of
prostacyclin synthase and nitric oxide synthase in subcutaneous arteries of type 2
diabetic patients. Tohoku J Exp Med 2013;231(3):217-22
217.
Saif-Ali R, Harun R, Kamaruddin NA, et al. Association of hepatocyte nuclear
factor 4 alpha polymorphisms with type 2 diabetes with or without metabolic
syndrome in Malaysia. Biochem Genet 2012;50(3-4):298-308
218.
Saif-Ali R, Ismail IS, Al-Hamodi Z, et al. KCNQ1 Haplotypes associate with type
2 diabetes in Malaysian Chinese subjects. Int J Mol Sci 2011;12(9):5705-18
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189745
219.
Saif-Ali R, Muniandy S, Al-Hamodi Z, et al. KCNQ1 variants associate with type
2 diabetes in Malaysian Malay subjects. Ann Acad Med Singapore 2011;40(11):488-92
220.
Saini R, Al-Maweri SA, Saini D, et al. Oral mucosal lesions in non oral habit
diabetic patients and association of diabetes mellitus with oral precancerous lesions.
Diabetes Res Clin Pract 2010;89(3):320-6
221.
Salem SD, Saif-Ali R, Ismail IS, et al. IGF2BP2 alternative variants associated
with glutamic acid decarboxylase antibodies negative diabetes in Malaysian subjects.
PLoS One 2012;7(9):e45573
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446917
222.
Salinatin MS, Mustaffa Halabi A, Adzrool Idzwan I. Diabetic healthcare
awareness in Malaysia: the role of poster as a communication medium. Procedia Social and Behavioral Sciences 2013;91:539-44
http://www.sciencedirect.com/science/article/pii/S1877042813025834
223.
Salmiah MA, Kamaruzaman J. Barriers to optimal control of type 2 diabetes in
Malaysian Malay patients. Glob J Health Sci 2009;1(2):106-18
http://www.ccsenet.org/journal/index.php/gjhs/article/view/3943/3479.
224.
Sayeeda R, Aziz Al-Safi I, Shaiful Bahari I, et al. Early manifestation of
macrovasculopathy in newly diagnosed never treated type II diabetic patients with no
traditional CVD risk factors. Diabetes Res Clin Pract 2008;80(2):253-8
225.
Sayeeda R, Aziz Al-Safi I, Shaiful Bahari I, et al. Effect of rosiglitazone/ramipril
on preclinical vasculopathy in newly diagnosed, untreated diabetes and IGT patients:
1-year randomised, double-blind, placebo-controlled study. Eur J Clin Pharmacol
2007;63(8):733-41
226.
Sazlina SG, Browning CJ, Mohd Shajahan MY. Promoting physical activity in
sedentary elderly Malays with type 2 diabetes: a protocol for randomised controlled
trial. BMJ Open 2012;2(6):10.1136/bmjopen,2012-002119. Print 2012
http://bmjopen.bmj.com/content/2/6/e002119.full.pdf
227.
Shafie O, Zainal Ariffin O. Role of health promotion in management of
cardiovascular diseases and diabetes mellitus. NCD Malaysia 2003;2(2):2-5
228.
Shahid HS, Kurdi MI, Zohair AA. Serum high-sensitivity C-reactive protein and
lipoprotein(a) levels: a comparison between diabetic and non-diabetic patients with
coronary artery disease. Med J Malaysia 2011;66(2):113-6
http://www.e-mjm.org/2011/v66n2/Coronary_Artery_Disease.pdf
229.
Shaik MM, Gan SH, Kamal MA. Epigenomic approach in understanding
Alzheimer's disease and type 2 diabetes mellitus. CNS Neurol Disord Drug Targets
2014;13(2):283-9.
230.
Shareef BT, Ang KT, Naik VR. Qualitative and quantitative exfoliative cytology
of normal oral mucosa in type 2 diabetic patients. Med Oral Patol Oral Cir Bucal
2008;13(11):E693-6
http://www.medicinaoral.com/pubmed/medoralv13_i11_p693.pdf

231.
Shariati NH, Zahedi E, Jajai HM. Classification of vascular function in upper
limb using bilateral photoplethysmographic signals. Physiol Meas 2008;29(3):365-74
232.
Sharmilla T, Ahmad Hatim S, Jambunathan ST. Prevalence of obesity, lipid and
glucose abnormalities in outpatients prescribed clozapine in University Malaya
Medical Center, Kuala Lumpur. Malaysian Journal of Psychiatry 2008;17(2):37-46
http://www.mjpsychiatry.org/index.php/mjp/article/viewFile/38/38
233.
Sharmini S, Uiterwaal CS, Jamaiyah H, et al. Renal impairment and all-cause
mortality in cardiovascular disease: effect modification by type 2 diabetes mellitus.
Eur J Clin Invest 2013;43(2):198-207
234.
Sharmini S, Fong AY, Selvaraj G, et al. An Asian validation of the TIMI risk score
for ST-segment elevation myocardial infarction. PLoS One 2012;7(7):e40249
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398026
235.
Sheikh Anwar A, Azmi KN, Hamidon B, et al. An open label comparative study
of glimepiride versus repaglinide in type 2 diabetes mellitus Muslim subjects during
the month of Ramadan. Med J Malaysia 2006;61(1):28-35
http://www.e-mjm.org/2006/v61n1/Type_2_Diabetes_Mellitus.pdf
236.
Shen H, Qi L, Tai ES, et al. Uncoupling protein 2 promoter polymorphism
-866G/A, central adiposity, and metabolic syndrome in Asians. Obesity (Silver Spring)
2006;14(4):656-61
237.
Sheu WHH, Ji LN, Nitiyanant W, et al. Hypoglycemia is associated with
increased worry and lower quality of life among patients with type 2 diabetes treated
with oral antihyperglycemic agents in the Asia-Pacific region. Diabetes Res Clin Pract
2012;96(2):141-8
238.
Shubashini G, Ting KN, Wong KT, et al. Convergence of tuberculosis and
diabetes mellitus: time to individualise pharmaceutical care. Int J Clin Pharm
2011;33(1):44-52.
239.
Siti Harnida MI, Najihah I, Nazaimoon WM, et al. Improvement in C-reactive
protein and advanced glycosylation end-products in poorly controlled diabetics is
independent of glucose control. Diabetes Res Clin Pract 2006;72(1):48-52.
240.
Siti Khuzaimah AS, Wu VS. Self-efficacy and self-care behavior of Malaysian
patients with type 2 diabetes: a cross sectional survey. Nurs Health Sci
2012;14(1):38-45
http://onlinelibrary.wiley.com/doi/10.1111/j.1442-2018.2011.00658.x/pdf
241.
Soewondo P, Mafauzy M, Jain AB, et al. Safety and effectiveness of insulin
detemir in type 2 diabetes: results from the ASEAN cohort of the A(1)chieve study.
Diabetes Res Clin Pract 2013;100 Suppl 1:S10-6
242.
Strojek K, Wan Mohamad WB, Khutsoane DT, et al. Once-daily initiation with
biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes
inadequately controlled with oral drugs: an open-label, multinational RCT. Curr Med
Res Opin 2009;25(12):2887-94
243.
Sudha V, Bairy KL, Shashikiran U, et al. Efficacy and tolerability of Dianex in
Type 2 diabetes mellitus: a non randomized, open label non-comparative study. Med J
Malaysia 2005;60(2):204-11
http://www.e-mjm.org/2005/v60n2/Type_2_Diabetes_Mellitus.pdf
244.
Suehazlyn Z, Zaiton D, Masni M, et al. A Summary of the Malaysian Clinical
Practice Guidelines: Management of Type 2 Diabetes Mellitus (4th Edition) 2009.
Journal of the ASEAN Federation of Endocrine Societies 2012;26(1):20-5
http://www.asean-endocrinejournal.org/images/ISSUE1/issue%201_261_mustapha_malaysian%20dm%20cpg.pdf.
245.
Suhaimi M. A cross-sectional study of erectile dysfunction amongst diabetic
patients in Kota Bharu, Kelantan. Jurnal Kesihatan Masyarakat 2001;7.

246.
Sulaiman IM, Lee HS, Balan S, et al. Intraoperative glycaemic control in non
insulin dependent diabetes mellitus: A comparison between normal saline and
Ringer's lactate. Medicine & health 2006;1(1):20-4
http://journalarticle.ukm.my/1847/1/04._20-24_(MH_010).pdf
247.
Suresh S, Zunaina E, Shatriah I, et al. Sensitivity and specificity of HRT and
OCT to detect diabetic macular edema. Journal of Diabetes & Metabolism
2012;S3:009
http://omicsonline.org/2155-6156/2155-6156-S3-009.pdf.
248.
Syed Azhar SS, Amer Hayat K, Abdul Razak AM, et al. Impact of diabetes
mellitus on treatment outcomes of tuberculosis patients in tertiary care setup. Am J
Med Sci 2013;345(4):321-5
http://www.captb.org/sites/default/files/documents/Gender.TB.DM.Malaysia.20123.pdf
249.
Syed Shahzad H, Kaeshaelya T, Syed Imran A, et al. Pregnancy complications,
mental health-related problems and type 2 diabetes mellitus in Malaysian women.
Diabetes Metab Syndr 2013;7(4):191-7
250.
Syed Wasif G, Syed Azhar SS, Shameni S. Prediction and rate of infections in
diabetes mellitus patients with diabetes ketoacidosis in Penang, Malaysia. Open
Journal of Epidemiology 2012;2:1-6
http://www.scirp.org/journal/PaperDownload.aspx?paperID=17233
251.
Taghavi SM, Fatemi SS, Rokni H. Cabergoline effect on blood sugar in type 2
diabetic patients with oral agent failure. Med J Malaysia 2012;67(4):390-2
http://www.e-mjm.org/2012/v67n4/Cabergoline.pdf
252.
Tam CL, Bonn G, Yeoh SH, et al. Investigating diet and physical activity in
Malaysia: education and family history of diabetes relate to lower levels of physical
activity. Front Psychol 2014;5:1328
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253661
253.
Tan AE, Norizah WM, Hayati AR, et al. Umbilical artery resistance index in
diabetic pregnancies: the associations with fetal outcome and neonatal septal
hypertrophic cardiomyopathy. J Obstet Gynaecol Res 2005;31(4):296-301
254.
Tan CE, Emmanuel SC, Tan BY, et al. Diabetes mellitus abolishes ethnic
differences in cardiovascular risk factors: lessons from a multi-ethnic population.
Atherosclerosis 2001;155(1):179-86
255.
Tan F, Liew SF, Chan G, et al. Improving diabetes care in a public hospital
medical clinic: report of a completed audit cycle. J Eval Clin Pract 2011;17(1):40-4
256.
Tan F, Chan G, Wong JS, et al. Standard of care for type 2 diabetic patients in a
public hospital general medical clinic: report of a self-audit. Med J Malaysia
2008;63(3):224-8
http://www.e-mjm.org/2008/v63n3/Type_2_Diabetic_Patients.pdf
257.
Tan MY, Magarey JM, Chee WSS, et al. A brief structured education programme
enhances self-care practices and improves glycaemic control in Malaysians with
poorly controlled diabetes. Health Educ Res 2011;26(5):896-907
http://her.oxfordjournals.org/content/26/5/896.full.pdf
258.
Tan MY, Magarey J. Self-care practices of Malaysian adults with diabetes and
sub-optimal glycaemic control. Patient Educ Couns 2008;72(2):252-67
259.
Tan SM, Shafiee Z, Wu LL, et al. Factors associated with control of type I
diabetes in Malaysian adolescents and young adults. Int J Psychiatry Med
2005;35(2):123-36
260.
Tan SF, Chia YC, Karuthan C. Rate of decline of kidney function in patients with
type 2 diabetes mellitus and the associated factors: A 10-year retrospective cohort
study. Asia Pac J Public Health 2013

261.
Tan SL, Juliana S, Sakinah H. Dietary compliance and its association with
glycemic control among poorly controlled type 2 diabetic outpatients in Hospital
Universiti Sains Malaysia. Malays J Nutr 2011;17(3):287-99
http://nutriweb.org.my/publications/mjn0017_3/2Tan%20SL.pdf
262.
Tan BL, Lim TA. Factors influencing post-operative hyperglycaemia in type 2
diabetes mellitus patients managed without intra-operative insulin. Med J Malaysia
2006;61(1):122-4
http://www.e-mjm.org/2006/v61n1/Diabetes_Mellitus.pdf
263.
Tan MC, Wong TW, Ng OC, et al. Metabolic syndrome components and
prevalence of cardiovascular disease among type 2 diabetic patients in Malaysia.
Southeast Asian J Trop Med Public Health 2014;45(1):226-35
264.
Teo CW, Chung WL, Khaw CR, et al. Hypertension and diabetes mellitus among
the residents of an old folks home in north Malaysia. Internet Journal of Geriatrics and
Gerontology 2009;6(1). http://ispub.com/IJGG/6/1/12653
265.
Thai AC, Mohan V, Khalid BA, et al. Islet autoimmunity status in Asians with
young-onset diabetes (12-40 years): association with clinical characteristics, beta cell
function and cardio-metabolic risk factors. Diabetes Res Clin Pract 2008;80(2):224-30
266.
Thevi T, Maslina B, Reddy SC. Prevalence of eye diseases and visual
impairment among the rural population - a case study of Temerloh Hospital.
Malaysian Family Physician 2012;7(1):6-10
http://www.e-mfp.org/ojs/index.php/MFP/article/view/14
267.
Vasanthakumar SS, Teng CL. EBM commentary: Should statins be started in all
type 2 diabetics irrespective of LDL-cholesterol level? Malaysian Family Physician
2007;2(2):75
http://www.e-mfp.org/2007v2n2/pdf/Should%20statins%20be%20started%20in%20all
%20type%202%20diabetics%20irrespective%20of%20LDL-cholesterol%20level.pdf;.
268.
Vasudevan R, Ismail P, Stanslas J, et al. Association of insertion/deletion
polymorphism of alpha-adrenoceptor gene in essential hypertension with or without
type 2 diabetes mellitus in Malaysian subjects. Int J Biol Sci 2008;4(6):362-7
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2567812
269.
Wan Mohamad WB, Lim-Abrahan MA, Jain AB, et al. Safety and effectiveness of
insulin aspart in type 2 diabetic patients: results from the ASEAN cohort of the
A(1)chieve study. Diabetes Res Clin Pract 2013;100 Suppl 1:S17-23
http://www.a1chieve.com/en/article/S0168-8227%2813%2970005-6/aim/.
270.
Wan Mohamad WB, Chow CC, Khalid AK, et al. Adding biphasic insulin aspart
30 once or twice daily is more efficacious than optimizing oral antidiabetic treatment
in patients with type 2 diabetes. Diabetes Obes Metab 2007;9(5):724-32
271.
Wan Mohamad WB, Tun Fizi A, Ismail RB, et al. Efficacy and safety of single
versus multiple daily doses of glibenclamide in type 2 diabetes mellitus. Diabetes
Res Clin Pract 2000;49(2-3):93-9
272.
Wan Nazaimoon WM, Siti Harnida MI, Wan Mohamad WB, et al. Prevalence of
diabetes in Malaysia and usefulness of HbA1c as a diagnostic criterion. Diabet Med
2013;30(7):825-8
http://www.researchgate.net/publication/235646155_Prevalence_of_diabetes_in_Mala
ysia_and_usefulness_of_HbA(1c)_as_a_diagnostic_criterion/file/60b7d525f3526e098b.
pdf.
273.
Wan Nazaimoon WM, Kamarul Imran M, Amir Sharifuddin MK, et al. Prevalence
of overweight and obesity among adult Malaysians: an update. Asia Pac J Clin Nutr
2011;20(1):35-41
http://apjcn.nhri.org.tw/server/APJCN/20/1/35.pdf
274.
Wan Nazaimoon WM, Suraiami M. Prevalence of diabetes, impared fasting
glucose and metabolic syndrome among female Orang Asli community in Peninsular

Malaysia. Int J Diabetes Dev Ctries 2010;30(3):118-22


http://www.rssdi.in/diabetesbulletin/2010/JULY/IntJDiabDevCtries303118296188_004921.pdf
275.
Wan Norlida I, Aljunid SM, Aniza I. Cost of type 2 diabetes mellitus in selected
developing countries. Malaysian Journal of Public Health Medicine 2010;10(2):68-71
http://pppkam.org.my/mjphm/journals/Volume10.2/8.Cost%20of%20Type
%202%20Diabetes%20(LASTT)(68-71)M%20(Last).pdf
276.
Wee HL, Li SC, Cheung YB, et al. The influence of ethnicity on health-related
quality of life in diabetes mellitus: a population-based, multiethnic study. J Diabetes
Complications 2006;20(3):170-8.
277.
Wee HL, Cheung YB, Li SC, et al. The impact of diabetes mellitus and other
chronic medical conditions on health-related Quality of Life: is the whole greater than
the sum of its parts? Health Qual Life Outcomes 2005;3:2
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC548134
278.
Wong KS, Hwang S, Han DC, et al. Losartan reduces the costs of diabetic endstage renal disease: an Asian perspective. Nephrology (Carlton) 2005;10(5):520-4
http://www.pkdiet.com/pdf/losartanreducesesrd.pdf
279.
Wong SSL, Ng CJ, Liew SM, et al. Effectiveness of a colour coded HbA1c
graphical record in improving diabetes control in people with type 2 diabetes: a
randomized control trial. Diabetes Res Clin Pract 2012;95(2):e41-4
280.
Yahaya H, Al-Jabil SW, Noorizan AA, et al. Statin use prior to ischemic stroke
onset is associated with decreased in-hospital mortality. Fundam Clin Pharmacol
2011;25(3):388-94
http://staff.najah.edu/sites/default/files/Statin_Use_Prior_To_Ischemic_Stroke_Onset_Is
_Associated_With_Decreased_In-Hospital_Mortality_0.pdf.
281.
Yahaya H, Noorizan AA, Al-Jabil SW, et al. Impact of angiotensin-converting
enzyme inhibitors administration prior to acute ischemic stroke onset on in-hospital
mortality. J Cardiovasc Pharmacol Ther 2010;15(3):274-81
ftp://82.239.144.183/bibli/-%20Revue%20Articles%20FB/Biblio%20101015%20rout
%E9e/213.1009-ACE%20inhibitors%20administration%20prior%20to%20acute
%20ischemic%20stroke%20onset%20on%20in-hospital%20mortality_Hassan,%20J
%20CV%20PT.pdf
282.
Yeo CK, Hapizah MN, Khalid AK, et al. The comparison of QT dispersion and 24
hour ambulatory blood pressure monitoring amongst diabetic patients with and
without microalbuminuria. Med J Malaysia 2004;59(2):185-9
http://www.e-mjm.org/2004/v59n2/Diabetic_Patients.pdf
283.
Yeo CK, Hapizah MN, Khalid BA, et al. New coronary risk factors: is there a
difference between diabetic patients with microalbuminuria compared to those
without microalbuminuria? Med J Malaysia 2002;57(3):298-303
http://www.e-mjm.org/2002/v57n3/Coronary_Risk_Factors.pdf
284.
Yunus R, Ariff AR, Shuaib IL, et al. A study of the factors related to intimamedia thickness of the common carotid artery amongst rural middle age individuals
in Hospital Universiti Sains Malaysia. Southeast Asian J Trop Med Public Health
2006;37(4):806-11
285.
Yusof BNM, Talib RA, Kamaruddin NA, et al. A low-GI diet is associated with a
short-term improvement of glycaemic control in Asian patients with type 2 diabetes.
Diabetes Obes Metab 2009;11(4):387-96
286.
Zainal Ariffin O, Ismail ASM, Fatanah I, et al. The characteristic of metabolic
syndrome risk factors among respondents with diabetes mellitus in Perlis. NCD
Malaysia 2005;4(3):3-7
287.
Zainal Ariffin O, Radziah I, Ishak J. Communty-based programmes in diabetes
control. NCD Malaysia 2002;1(2):12-5

288.
Zaki NF, Sulaiman AS, Gillani WS. Clinical evaluation of dyslipidemia among
type II diabetic patients at public hospital Penang, Malaysia. Int Arch Med
2010;3:34,7682-3-34
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002890.
289.
Zakuan ZD, Habsah H, Mohd Suhaimi AW, et al. The association between premorbid conditions and respiratory tract manifestations amongst Malaysian Hajj
pilgrims. Trop Biomed 2010;27(2):294-300
http://msptm.org/files/294_-_300_Zakuan_Zainy_Deris.pdf
290.
Zaman Huri H, Permalu V, Vethakkan SR. Sliding-scale versus basal-bolus
insulin in the management of severe or acute hyperglycemia in type 2 diabetes
patients: a retrospective study. PLoS One 2014;9(9):e106505
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4152280
291.
Zanariah H, Lim-Abrahan MA, Jain AB, et al. Switching from biphasic human
insulin to biphasic insulin aspart 30 in type 2 diabetes: results from the ASEAN
subgroup of the A(1)chieve study. Diabetes Res Clin Pract 2013;100 Suppl 1:S24-9
http://www.a1chieve.com/en/article/S0168-8227%2813%2970006-8/fulltext
PRIMARY CARE RESEARCH
1. Addoor KR, Bhandary SV, Khanna R, et al. Assessment of awareness of diabetic
retinopathy among the diabetics attending the peripheral diabetic clinics in Melaka,
Malaysia. Med J Malaysia 2011;66(1):48-52
http://www.e-mjm.org/2011/v66n1/Diabetes_mellitus.pdf
2. Azura M, Adibah Hanim I, Juwita S. Risk factor of peripheral neuropathy among newly
diagnosed type 2 diabetic patients in primary care clinic. International Journal of
Collaborative Research on Internal Medicine & Public Health 2012;4(11):1858-67
http://www.iomcworld.com/ijcrimph/files/v04-n11-05.pdf
3. Azwany N, Aziz AI, Mohammad W. The impact of Ramadan fasting on hydration status
of type 2 diabetics in Kubang Kerian, Kelantan. Jurnal Kesihatan Masyarakat
2004;10:31-4
http://journalarticle.ukm.my/4436/1/2004-02nizam.pdf
4. Badariah A, Khalid AK, Anuar Zaini MZ, et al. Influencing factors of glycaemic control
in patients attending different types of urban health care settings in Malaysia.
Diabetes Res Clin Pract 2011;93(1):e12-4
5. Chan GC. Type 2 diabetes mellitus with hypertension at primary healthcare level in
Malaysia: are they managed according to guidelines? Singapore Med J
2005;46(3):127-31
http://www.sma.org.sg/smj/4603/4603a3.pdf
6. Chan GC, Ghazali O, Khoo EM. Management of type 2 diabetes mellitus: is it in
accordance with the guidelines? Med J Malaysia 2005;60(5):578-84
http://www.e-mjm.org/2005/v60n5/Type_2_Diabetes_Mellitus.pdf
7. Chan SC, Lee TW, Teoh LC, et al. Audit on cardiovascular disease preventive care in
general practice. Singapore Med J 2008;49(4):311-5
http://smj.sma.org.sg/4904/4904a6.pdf
8. Chan SC. Has diabetic management in the Outpatient Department, Hospital Ipoh
improved over the years? Medical Practice Hospital Ipoh 2003;6(1):36-8
9. Cheah WL, Lee PY, Lim PY, et al. Perception of quality of life among people with
diabetes. Malaysian Family Physician 2012;7(2&3):21-30
http://e-mfp.org/issues/2012v7n2_3/Diabetes-quality-of-life.pdf
10. Cheong AT, Lee PY, Sazlina SG, et al. Poor glycemic control in younger women
attending Malaysian public primary care clinics: findings from adults diabetes control
and management registry. BMC Fam Pract 2013;14:188,2296-14-188
http://www.biomedcentral.com/content/pdf/1471-2296-14-188.pdf

11. Cheong AT, Tong SF, Sazlina SG, et al. Blood pressure control among hypertensive
patients with and without diabetes mellitus in six public primary care clinics in
Malaysia. Asia Pac J Public Health 2013
12. Cheong AT, Zaiton A, Chew BH. Metabolic control and cardiovascular risk factors
among type 2 diabetes in a primary care clinic. Malaysian Journal of Medicine and
Health Sciences 2012;8(1):5-12
http://medic.upm.edu.my/images/stories/journal/VOL8NO1_JANUARI2012.pdf
13. Chew BH, Mastura I, Mohamad Adam B. Comparing the disease profiles of adult
patients with type 2 diabetes mellitus attending four public health care facilities in
Malaysia. Malaysian Family Physician 2013;8(1):11-8
http://www.e-mfp.org/pdf/2013v8n3/type-2-diabetes-mellitus.pdf
14. Chew BH, Sazlina SG, Lee PY, et al. Type 2 diabetes mellitus patient profiles, diseases
control and complications at four public health facilities - a cross-sectional study
based on the Adult Diabetes Control and Management (ADCM) registry 2009. Med J
Malaysia 2013;68(5):397-404
http://www.e-mjm.org/2013/v68n5/type-2-diabetes-mellitus.pdf
15. Chew BH, Sazlina SG, Mastura I, et al. Age >/= 60 years was an independent risk
factor for diabetes-related complications despite good control of cardiovascular risk
factors in patients with type 2 diabetes mellitus. Exp Gerontol 2013;48(5):485-91
16. Chew BH, Cheong AT, Zaiton A, et al. Men suffer more complications from diabetes
than women despite similar glycaemic control and a better cardiovascular risk profile:
the ADCM study 2008. Journal of Men's Health 2012;9(3):190-7
17. Chew BH, Mastura I, Lee PY, et al. Determinants of uncontrolled dyslipidaemia among
adult type 2 diabetes in Malaysia: the Malaysian Diabetes Registry 2009. Diabetes
Res Clin Pract 2012;96(3):339-47
18. Chew BH, Mastura I, Sazlina SG, et al. Determinants of uncontrolled hypertension in
adult type 2 diabetes mellitus: an analysis of the Malaysian diabetes registry 2009.
Cardiovasc Diabetol 2012;11:54,2840-11-54
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434063
19. Chew BH, Palikat JM, Nur Syamimi A, et al. An audit of type 2 diabetes care in a
Malaysian public community polyclinic. Pertanika Journal of Science & Technology
2012;20(1):97-102
http://www.pertanika2.upm.edu.my/Pertanika%20PAPERS/JST%20Vol.
%2020%20%281%29%20Jan.%202012/14%20Pg%2097-102.pdf
20. Chew BH, Khoo EM, Chia YC. Does religious affiliation influence glycaemic control in
primary care patients with type 2 diabetes mellitus? Ment Health Fam Med
2011;8(1):21-8
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3134210
21. Chew BH, Khoo EM, Chia YC. Social support and glycemic control in adult patients
with type 2 diabetes mellitus. Asia Pac J Public Health
2011;http://www.researchgate.net/publication/51924846_Social_Support_and_Glycem
ic_Control_in_Adult_Patients_With_Type_2_Diabetes_Mellitus/file/32bfe5101de982343
3.pdf.
22. Chew BH, Khoo EM, Chia YC. Quality of care for adult type 2 diabetes mellitus at a
university primary care centre in Malaysia. International Journal of Collaborative
Research on Internal Medicine & Public Health 2011;3(6):439-49
http://iomcworld.com/ijcrimph/files/v03-n06-03.pdf
23. Chew BH, Mastura I, Lee PY, et al. Ethnic differences in glycaemic control and
complications: the adult diabetes control and management (ADCM), Malaysia. Med J
Malaysia 2011;66(3):244-8
http://www.e-mjm.org/2011/v66n3/Glycaemic_control.pdf

24. Chew BH, Mastura I, Cheong AT, et al. Diabetic hypertensive control and treatment: A
descriptive report from the audit diabetes control and management (ADCM) registry.
Malaysian Family Physician 2010;5(3):134-9
http://www.e-mfp.org/2010v5n3/pdf/diabetic_hypertensive.pdf
25. Ching SM, Zainul Amiruddin Z, Fuziah P, et al. Complementary alternative medicine
use among patients with type 2 diabetes mellitus in the primary care setting: a crosssectional study in Malaysia. BMC Complement Altern Med 2013;13:148,6882-13-148
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701537
26. Chua SS, Kok LC, Faridah Aryani MY, et al. Pharmaceutical care issues identified by
pharmacists in patients with diabetes, hypertension or hyperlipidaemia in primary
care settings. BMC Health Serv Res 2012;12:388,6963-12-388
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529120
27. Ding CH, Teng CL, Koh CN. Knowledge of diabetes mellitus among diabetic and nondiabetic patients in Klinik Kesihatan Seremban. Med J Malaysia 2006;61(4):399-404
http://www.e-mjm.org/2006/v61n4/Knowledge_Diabetes_Mellitus.pdf
28. Draman S, Aris MAM, Razman, et al. Mas Cotek (Ficus deltoidea): a possible
supplement for type II diabetes: (a pilot study). Pertanika Journal of Tropical
Agricultural Science 2012;35(1):93-102
http://www.pertanika2.upm.edu.my/Pertanika%20PAPERS/JTAS%20Vol.
%2035%20%281%29%20Feb.%202012/17%20Pg%2093-102.pdf
29. Faridah K, Azmi MT. Retrospective study of predictors for foot ulceration among
diabetic patients attending Kuala Langat Health Centre from 1999 to 2008. Jurnal
Kesihatan Masyarakat 2009;15(2):43-59
http://journalarticle.ukm.my/276/1/1.pdf
30. Fauziah MN, Suhaiza S. A review of diabetic complications amongst poorly controlled
diabetes at 8 health clinics in Kelantan. NCD Malaysia 2004;3(2):13-6
31. Feisul Idzwan M, Mohd Idris MN. Incidence of microalbuminuria and its influencing
factors among patients with type 2 diabetes at Klinik Kesihatan Seremban, Malaysia,
from 2000 until 2005. International Medical Journal (Tokyo) 2008;15(4):249-55
32. Gurpreet K, Tee GH, Suthahar A, et al. Depression, anxiety and stress symptoms
among diabetics in Malaysia: a cross sectional study in an urban primary care setting.
BMC Fam Pract 2013;14:69,2296-14-69
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669622
33. Hasliza AH, Hizlinda T, Rahmah MA, et al. Factors influencing insulin acceptance
among type 2 diabetes mellitus patients in a primary care clinic: a qualitative
exploration. BMC Fam Pract 2013;14(1):164
http://www.biomedcentral.com/content/pdf/1471-2296-14-164.pdf
34. Hasni I, Adibah Hanim I, Shaiful Bahari I, et al. The use of HbA1C in the diagnosis of
diabetes mellitus type 2 in high risk subjects. International Journal of Diabetes &
Metabolism 2010;18:25-8
http://ijod.uaeu.ac.ae/iss_1801/e.pdf
35. Hassan NH, Juwita S, Azidah AK, et al. Study on the effect of oral hypoglycaemic
agents on arterial stiffness among Malays with type II diabetes mellitus .
International Journal of Diabetes & Metabolism 2007;15:116-20
http://ijod.uaeu.ac.ae/iss_1801/e.pdf
36. Keah RSH, Ch'ng KS. Prevalence of diabetic retinopathy in a primary care setting
using digital retinal imaging technology. Malaysian Family Physician 2006;1(1):19-22
http://www.e-mfp.org/old/v1n1/pdf/diabetic_retinopathy.pdf
37. Khatoon R, Khoo EM. Prevalence of peripheral arterial disease in patients with
diabetes mellitus in a primary care setting. Med J Malaysia 2007;62(2):130-3
http://www.e-mjm.org/2007/v62n2/Peripheral_Arterial_Disease.pdf

38. Kong NC, Chia YC, Khalid AK, et al. Microalbuminuria prevalence study in
hypertensive type 2 diabetic patients in Malaysia. Med J Malaysia 2006;61(4):457-65
http://www.e-mjm.org/2006/v61n4/Microalbuminuria.pdf
39. Lee PY, Cheong AT, Zaiton A, et al. Does ethnicity contribute to the control of
cardiovascular risk factors among patients with type 2 diabetes? Asia Pac J Public
Health 2013;25(4):316-25
40. Lee PY, Lee YK, Ng CJ. How can insulin initiation delivery in a dual-sector health
system be optimised? A qualitative study on healthcare professionals' views. BMC
Public Health 2012;12:313
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533841
41. Lee TW, Chan SC, Chua WT, et al. Audit of diabetes mellitus in general practice. Med J
Malaysia 2004;59(3):317-22
http://www.e-mjm.org/2004/v59n3/Audit_of_Diabetes_Mellitus.pdf
42. Lee YK, Ng CJ, Lee PY, et al. What are the barriers faced by patients using insulin? A
qualitative study of Malaysian health care professionals' views. Patient Prefer
Adherence 2013;7:103-9
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3559078/pdf/ppa-7-103.pdf
43. Lee YK, Lee PY, Ng CJ. A qualitative study on healthcare professionals' perceived
barriers to insulin initiation in a multi-ethnic population. BMC Fam Pract
2012;13:28,2296-13-28
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389339
44. Leelavathi M, Noor Azimah M, Kharuddin NF, et al. Prevalence of toenail
onychomycosis among diabetics at a primary care facility in Malaysia. Southeast
Asian J Trop Med Public Health 2013;44(3):479-83
http://www.tm.mahidol.ac.th/seameo/2013-44-3-full/15-5647-6.pdf
45. Leelavathi M, Noor Azimah M, Kharuddin NF, et al. Microorganisms responsible for
onychomycosis among diabetic patients. [Mikroganisama penyebab jangkitan kulat
kuku kalangan pesakit kencing manis.]. Sains Malaysiana 2013;42(3):359-63
http://www.ukm.my/jsm/pdf_files/SM-PDF-42-3-2013/12%20M.%20Leelavathi.pdf
46. Liew SM, Lee PY, Nik Sherina Haidi H, et al. Statins use is associated with poorer
glycaemic control in a cohort of hypertensive patients with diabetes and without
diabetes. Diabetol Metab Syndr 2014;6:53,5996-6-53. eCollection 2014
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003286
47. Lim CJ, Suzana S, Hanis Mastura Y, et al. Level of nutritional knowledge and health
awareness among diabetes mellitus patients at cheras health clinic, Kuala Lumpur,
Malaysia. Sains Malaysiana 2010;39(3):505-11
http://www.ukm.my/jsm/pdf_files/SM-PDF-39-3-2010/24%20Lim%20Ching.pdf
48. Low CF, Eusni Rahayu MT, Chong PP, et al. Adiponectin SNP45TG is associated with
gestational diabetes mellitus. Arch Gynecol Obstet 2011;283(6):1255-60
http://www.researchgate.net/publication/232292935_MATERNOFETAL_MEDICINE_Adiponectin_SNP45TG_is_associated_with_gestational_diabetes_mel
litus/file/9fcfd50817ddd9255c.pdf
49. Low WHH, Seet W, Anis Safura R, et al. Community-based cardiovascular Risk Factors
Intervention Strategies (CORFIS) in managing hypertension: A pragmatic nonrandomised controlled trial. Med J Malaysia 2013;68(2):129-35
http://www.e-mjm.org/2013/v68n2/CORFIS-in-managing-hypertension.pdf
50. Mafauzy M. Diabetes control and complications in private primary healthcare in
Malaysia. Med J Malaysia 2005;60(2):212-7
http://www.e-mjm.org/2005/v60n2/Diabetes_Control.pdf
51. Mallika P, Aziz S, Goh PP, et al. Diabetic retinopathy in native and non-native
Sarawakians--findings from the Diabetic Eye Registry. Med J Malaysia 2012;67(4):369-

74
http://www.e-mjm.org/2012/v67n4/Diabetic-retinopathy.pdf
52. Mallika PS, Lee PY, Cheah WL, et al. Risk factors for diabetic retinopathy in diabetics
screened using fundus photography at a primary health care setting in east Malaysia.
Malaysian Family Physician 2011;6(2&3):60-5
http://www.e-mfp.org/2011v6n2_3/pdf/risk_of_diabetic_retinopathy.pdf
53. Mariam M, Osman A. An Intervention study of exercise-Qigong program on quality of
life and cardiovasular risk factor control among type 2 diabites mellitus patient at
Beranang Health Center, Hulu Langat. Borneo Journal of Medical Sciences 2007;1.
54. Mastura I, Teng CL, Mimi O, et al. Usage of glucometer is associated with improved
glycaemic control in type 2 diabetes mellitus patients in Malaysian public primary
care clinics: an open-label, randomised controlled trial. Singapore Med J
2013;54(7):391-5
http://www.sma.org.sg/UploadedImg/files/SMJ/5407/5407a3.pdf
55. Mastura I, Chew BH, Lee PY, et al. Control and treatment profiles of 70,889 adult type
2 diabetes mellitus patients in Malaysia - a cross sectional survey in 2009.
International Journal of Collaborative Research on Internal Medicine & Public Health
2011;3(1):98-113
http://www.iomcworld.com/ijcrimph/files/v03-n01-10.pdf.
56. Mastura I, Mimi O, Piterman L, et al. Self-monitoring of blood glucose among diabetes
patients attending government health clinics. Med J Malaysia 2007;62(2):147-51
http://www.e-mjm.org/2007/v62n2/Self-Monitoring_Blood_Glucose.pdf
57. Mimi O, Teng CL, Chia YC. Clinical tests for diabetic peripheral neuropathy - which
modality to choose? FMS Malaysia 2004;2(1):11-3.
58. Mimi O, Teng CL, Chia YC. The prevalence of diabetic peripheral neuropathy in an
outpatient setting. Med J Malaysia 2003;58(4):533-8
http://www.e-mjm.org/2003/v58n4/Diabetic_Peripheral_Neuropathy.pdf
59. Mohd Faudzi A, Norsiah MN, Siti Zubaidah MA, et al. Validation of the comprehensive
ICF core sets for diabetes mellitus:a Malaysian perspective. Ann Acad Med Singapore
2011;40(4):168-78
http://www.annals.edu.sg/pdf/40VolNo4Apr2011/V40N4p168.pdf
60. Moy FM, Suriah AR. Anthropometry and dietary intake of type 2 diabetes patients
attending an outpatient clinic. Malays J Nutr 2002;8(1):63-73
http://nutriweb.org.my/publications/mjn008_1/mjn8n1_art5.pdf
61. Nabila A, M.Dzaki S, Zainal Ariffin O, et al. Direct costs of diabetes in an outpatient
setting in Malaysia. NCD Malaysia 2003;2(1):19-27.
62. Nazimah I, Che Hatikah CH, Murizah MZ, et al. Universal versus selective screening
for detection of gestational diabetes mellitus in a Malaysian population. Malaysian
Family Physician 2009;4(2&3):83-7
http://www.e-mfp.org/old/2009v4n2_3/pdf/gestational_diabetes_mellitus.pdf
63. Nik Sherina Haidi H, Teng CL, Mohd Shajahan MY. Continuity of care of diabetic
patients in a family practice clinic: How important is it? Asia Pac Fam Med
2003;2(1):10-5
http://www.apfmj-archive.com/afm2.1/afm_044.pdf
64. Noor Azimah M, Radzniwan AR, Zuhra H, et al. Have we done enough with diabetic
education? A pilot study. Malaysian Family Physician 2010;5(1):24-30
http://www.e-mfp.org/2010v5n1/pdf/Diabetic_education.pdf
65. Noor Salihah Z, Lua PL, Nik Mazlan M. Body weight satisfaction: association with
weight control practices among type 2 diabetic patients. Malays J Nutr 2011;17(1):5566
http://nutriweb.org.my/publications/mjn0017_1/salihahLua%28%285%29%28edSP
%29%28RV%29rev.pdf

66. Nor Shazwani MN, Suzana S, Hanis Mastura Y, et al. Assessment of physical activity
level among individuals with type 2 diabetes mellitus at Cheras Health Clinic, Kuala
Lumpur. Malays J Nutr 2010;16(1):101-12
http://nutriweb.org.my/publications/mjn0016/Shazwani(edSP)101-112.pdf
67. Norhafizah S, Tahir A, Ahmad Sharifuddin MA, et al. Oral health seeking behaviour
among Malaysians with type II diabetes. Journal of Public Health Aspects
2014;http://www.hoajonline.com/journals/pdf/2055-7205-1-1.pdf
68. Norma S, Azmi MT, Rotina A. Factors that influence albuminuria among type 2
diabetes mellitus at primary healthcare clinics in Negeri Sembilan 2007. Jurnal
Kesihatan Masyarakat 2010;16(1):21-32
http://journalarticle.ukm.my/265/1/1.pdf.
69. Nur Azmiah Z, Zulkarnain AK, Tahir A. Psychological insulin resistance (PIR) among
type 2 diabetes patients at public health clinics in Federal Territory of Malaysia.
International Medical Journal (IIUM) 2011;10(2):7-12
http://iiumedic.net/imjm/v1/download/Volume%2010%20No%202/IMJM%20Vol
%2010%20No%202%20p09-14.pdf
70. Nur Sufiza A, Farida I, Paraidathathu T. Factors associated with good glycemic control
among patients with type 2 diabetes mellitus. J Diabetes Investig 2014;5(5):563-9
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188115
71. Nur Sufiza A, Azuana R, Farida I, et al. Medication adherence in patients with type 2
diabetes mellitus treated at primary health clinics in Malaysia. Patient Prefer
Adherence 2013;7:525-30
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693921
72. Omar M, Mariam AM. Monitoring of cardiovascular screening programme and
combined diabetic/hypertensive clinic: experience from the districts. NCD Malaysia
2002;1(1):28-31
73. Ooi CP, Loke SC, Zaiton A, et al. Cross-sectional study of older adults with type 2
diabetes mellitus in two rural public primary healthcare facilities in Malaysia. Med J
Malaysia 2011;66(2):108-12
http://www.e-mjm.org/2011/v66n2/Type_2_Diabetes_Mellitus.pdf
74. Rabia K, Khoo EM. Is the Edinburgh Claudication Questionnaire a good screening tool
for detection of peripheral arterial disease in diabetic patients? Asia Pac Fam Med
2007;6(1)http://www.apfmj.com/afm6_1/afm54_.pdf
75. Rahmah MA, Noraishah J. Determinants of glucose control among elderly diabetics in
Kulim. Medicine & health 2011;6(2):78-85
http://www.ppukm.ukm.my/ukmmcjournal
76. Ranjini A, Subashini A, Ling HM. A knowledge, attitude and practice (KAP) study of
diabetes mellitus among patients attending Klinik Kesihatan Seri Manjung. NCD
Malaysia 2003;2(2):6-16
77. Reddy SC, Kihn YM, Nurjahan MI, et al. Retinopathy in type 2 diabetic patients with
microalbuminuria. Nepal J Ophthalmol 2013;5(1):69-74
http://nepjol.info/index.php/NEPJOPH/article/view/7830/6389
78. Remli R, Chan SC. Use of complementary medicine amongst diabetic patients in a
public primary care clinic in Ipoh. Med J Malaysia 2003;58(5):688-93
http://www.e-mjm.org/2003/v58n5/Complementary_Medicine.pdf
79. Rohana D, Wan Norlida WI, Nor Azwany Y, et al. Economic evaluation of type 2
diabetes management at the Malaysian Ministry of Health primary care clinics, in
Machang, Kelantan. Malaysian Journal of Public Health Medicine 2007;7(1):5-13
http://www.mjphm.org.my/mjphm/journals/Volume%207%20(1)%20:%202007/513.pdf
80. Rosediani M, Azidah AK, Mafauzy M. Correlation between fasting plasma glucose, post
prandial glucose and glycated haemoglobin and fructosamine. Med J Malaysia

2006;61(1):67-71
http://www.e-mjm.org/2006/v61n1/Plasma_Glucose.pdf
81. Sazlina K, Siti Balkis B, Yau M, et al. Relationship between sensory neuropathy and
body imbalance among diabetic Malay women. Sains Malaysiana 2011;40(8):945-51
http://www.ukm.my/jsm/pdf_files/SM-PDF-40-8-2011/18%20Sazlina.pdf
82. Sazlina K, Hatta S, Matthew Y, et al. Sexual function of Malay women with type 2
diabetes mellitus: a preliminary study. ASEAN Journal of Psychiatry 2010;11(1):64-71
http://www.aseanjournalofpsychiatry.org/pdf/ASEAN_3_15.pdf
83. Sazlina SG, Mastura I, Zaiton A, et al. Control of glycemia and other cardiovascular
disease risk factors in older adults with type 2 diabetes mellitus: Data from the Adult
Diabetes Control and Management. Geriatr Gerontol Int 2014;14(1):130-7
84. Sazlina SG, Zailinawati AH, Zaiton A, et al. A clinical audit on diabetes care in two
urban public primary care clinics in Malaysia. Malaysian Journal of Medicine and
Health Sciences 2010;6(1):101-9
http://medic.upm.edu.my/images/stories/journal/VOL6NO1_JANUARY2010.pdf
85. Shahidan H, Noorlia Y, Azlina I, et al. Diabetic management: home-based versus
chinic-based plasma glucose monitoring. NCD Malaysia 2003;2(4):7-10
86. Sharifa Ezat WP, Azimatun Noor A, Amrizal M, et al. Economic burden of diabetic care
in government health facilities in Selangor. Jurnal Kesihatan Masyarakat
2009;15(2):17-26
http://journalarticle.ukm.my/273/1/1.pdf
87. Shekhar KC, Achike FI, Gurpreet K, et al. A preliminary evaluation of the efficacy and
safety of Cogent db (an ayurvedic drug) in the glycemic control of patients with type
2-diabetes. J Altern Complement Med 2002;8(4):445-57
88. Sherina MS, Jefferelli SB, Zaiton A, et al. A study on the association of depression and
chronic disease among elderly patients attending a primary care clinic. Malaysian
Journal of Psychiatry 2002;10(1):8-12
89. Suhaiza S, Ahmad Nasir M, Jeriah I, et al. Glycaemic control among type 2 diabetic
patients in Kelantan. NCD Malaysia 2004;3(3):2-5
90. Tan CE, Tohit N, Shamsul A, Shah, et al. Chronic kidney disease stage 3B among
Malaysian diabetics in primary care and its associated factors: a pilot 5-year case
control study. Medicine & health 2013;8(2):55-63
http://www.medicineandhealthukm.com/system/files/article/2014/MS173.pdf
91. Tan MY. The relationship of health beliefs and complication prevention behaviors of
Chinese individuals with type 2 diabetes mellitus. Diabetes Res Clin Pract
2004;66(1):71-7
92. Umi A, Md. Idris MN, Osman A. Risk factors for diabetic nephropathy among noninsulin dependent patients who attended City Hall's Staff Clinic in Kuala Lumpur.
Malaysian Journal of Public Health Medicine 2001;1:16-21
http://www.mjphm.org.my/mjphm/journals/Volume%201%20:%202001/16-21.pdf.
93. Wong JS, Tan F, Lee PY. The state of lipid control in patients with diabetes in a public
health care centre. Asia Pac J Public Health 2007;19(3):16-21
94. Wong JS. Proteinuria in diabetic patients in a primary health care setting in Sarawak.
Med J Malaysia 2005;60(2):146-50
http://www.e-mjm.org/2005/v60n2/Proteinuria.pdf
95. Wong JS, Rahimah N. Glycaemic control of diabetic patients in an urban primary
health care setting in Sarawak: the Tanah Puteh Health Centre experience. Med J
Malaysia 2004;59(3):411-7
http://www.e-mjm.org/2004/v59n3/Glycaemic_Control_Diabetic.pdf
96. Yong SP, Siti Balkis B, Sazlina K. Foot sensation status of Malay women with type 2
diabetes mellitus. Jurnal Sains Kesihatan Malaysia 2012;10(2):43
http://journalarticle.ukm.my/6366/1/43-47.pdf

97. Zaki Morad MZ, Robaayah Z, Chan SP, et al. Optimal cut-off levels to define obesity:
body mass index and waist circumference, and their relationship to cardiovascular
disease, dyslipidaemia, hypertension and diabetes in Malaysia. Asia Pac J Clin Nutr
2009;18(2):209-16
http://apjcn.nhri.org.tw/server/APJCN/18/2/209.pdf
Case reports
1. Chan AC, Rohan MJ, Hamid A, et al. Emphysematous pyelonephritis in a diabetic
patient with pelvic-ureteric stone. Med J Malaysia 2007;62(2):166-7
http://www.e-mjm.org/2007/v62n2/Emphysematous_Pyelonephritis.pdf.
2. Cheong B. Metformin: a differential diagnosis for weight loss, altered bowel habits
and B12 deficiency anemia in an elderly diabetic. Med J Malaysia 2013;68(5):441-2
3. Dinesh RG, Avatar S, Haron A, et al. Nasal septal abscess with uncontrolled diabetes
mellitus: case reports. Med J Malaysia 2011;66(3):253-4
http://www.e-mjm.org/2011/v66n3/Nasal_septal_abscess.pdf.
4. Helmi S, Sasheela P, Mun KS, et al. Cervical abscesses due to co-infection with
Burkholderia pseudomallei, Salmonella enterica serovar Stanley and Mycobacterium
tuberculosis in a patient with diabetes mellitus. BMC Infect Dis 2013;13:527,2334-13527
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829705/.
5. Kamaliah MD, Bhajan MA, Dzarr GA. Emphysematous pyelonephritis caused by
Candida infection. Southeast Asian J Trop Med Public Health 2005;36(3):725-7.
6. Kumar S, Yushak AW, Gul YA. Intra-abdominal haemangiopericytoma associated with
uncontrolled diabetes mellitus. Med J Malaysia 2004;59(3):425-7
http://www.e-mjm.org/2004/v59n3/Hemangiopericytoma.pdf
7. Lim S, Norlisah R, Tai SML, et al. Involuntary movements in an elderly woman with
recently diagnosed diabetes. J Clin Neurosci 2011;18(4):539, 590
8. Mohd Hadzri H, Azarisman Shah MS, Suhaimi A, et al. Disseminated histoplasmosis
presenting with chronic ulcerative tongue lesions in a patient with diabetes. BMJ Case
Rep 2010;2010:10.1136/bcr.06.2010.3120
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3029345
9. Mohd Hadzri H, Azarisman Shah MS, Fauzi AR, et al. Invasive rhinocerebral
mucormycosis with orbital extension in poorly-controlled diabetes mellitus. Singapore
Med J 2009;50(3):e107-9
http://smj.sma.org.sg/5003/5003cr7.pdf
10. Murty OP. Diabetic artefacts in forensic practice. J Forensic Leg Med 2009;16(4):21823.
11. Neetu G, Pathmanathan R, Weng NK. Diabetic mastopathy: a case report and
literature review. Case Rep Oncol 2010;3(2):245-51
http://www.karger.com/Article/Pdf/318641
12. Norlinah MI, Ngow HA, Hamidon B. Angioinvasive cerebral aspergillosis presenting as
acute ischaemic stroke in a patient with diabetes mellitus. Singapore Med J
2007;48(1):e1-4
http://smj.sma.org.sg/4801/4801cr1.pdf
13. Ong YC, Su LH, Anuar Zaini MZ. Reversal of metabolic dysfunction through polyvalent
pharmacotherapy-augmented lifestyle intervention: case reports. Journal of Diabetes
& Metabolism 2011;2(5):1000133
http://omicsonline.org/2155-6156/2155-6156-2-133.pdf
14. Sathya K, Balamanikandasrinivasan C, Senthilkumar M, et al. Thermal burn of palate
in an elderly diabetic patient. Gerodontology 2014;31(2):149-52

15. Saw A, Kwan MK, Sengupta S. Necrotising fasciitis: a life-threatening complication of


acupuncture in a patient with diabetes mellitus. Singapore Med J 2004;45(4):180-2
http://www.sma.org.sg/smj/4504/4504cr1.pdf
16. Shalini B, Salmah W, Tharakan J. Diabetic non-ketotic hyperglycemia and the
hemichorea-hemiballism syndrome: A report of four cases. Neurology Asia
2010;15(1):89-91
http://www.neurology-asia.org/articles/20101_089.pdf
17. Sherina MS, Rozali A. Dietary management of a patient with diabetes mellitus: a case
report. Malays J Nutr 2003;9(2):137-44
http://nutriweb.org.my/publications/mjn009_2/mjn9n2_art6.pdf
18. Sherina MS, Shiran MS. Psychosocial issues in an adolescent with diabetes mellitus.
Family Physician 2003;12(2):17-8
19. Venugopal B, Wong KT, Goto YI, et al. Mitochondrial disorder, diabetes mellitus, and
findings in three muscles, including the heart. Ultrastruct Pathol 2006;30(3):135-41

Anda mungkin juga menyukai